MCID: HPT067
MIFTS: 43

Hepatocellular Adenoma

Categories: Cancer diseases, Endocrine diseases, Gastrointestinal diseases, Liver diseases, Rare diseases

Aliases & Classifications for Hepatocellular Adenoma

MalaCards integrated aliases for Hepatocellular Adenoma:

Name: Hepatocellular Adenoma 12 58 15 17 71
Adenoma Hepatocellular 54

Characteristics:

Orphanet epidemiological data:

58
hepatocellular adenoma
Age of onset: Adult;

Classifications:

Orphanet: 58  
Rare hepatic diseases


External Ids:

Disease Ontology 12 DOID:0050868
MESH via Orphanet 44 D018248
ICD10 via Orphanet 33 D13.4
UMLS via Orphanet 72 C0206669
Orphanet 58 ORPHA54272
UMLS 71 C0206669

Summaries for Hepatocellular Adenoma

Disease Ontology : 12 A liver benign neoplasm that is located in liver cells and that is composed of epithelial tissue in which tumor cells form glands or glandlike structures.

MalaCards based summary : Hepatocellular Adenoma, also known as adenoma hepatocellular, is related to liver adenomatosis and glycogen storage disease. An important gene associated with Hepatocellular Adenoma is HNF1A (HNF1 Homeobox A), and among its related pathways/superpathways are Metabolism and Drug metabolism - cytochrome P450. The drugs Liver Extracts and Hematinics have been mentioned in the context of this disorder. Affiliated tissues include liver cells, liver and bone, and related phenotypes are homeostasis/metabolism and liver/biliary system

Wikipedia : 74 Hepatocellular adenoma (also known as hepatic adenoma or hepadenoma) is a rare, benign liver tumor. It... more...

Related Diseases for Hepatocellular Adenoma

Diseases related to Hepatocellular Adenoma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 152, show less)
# Related Disease Score Top Affiliating Genes
1 liver adenomatosis 30.8 HNF1A CTNNB1
2 glycogen storage disease 30.4 SLC37A4 HNF1A G6PC AFP
3 peliosis hepatis 29.5 GLUL AFP
4 hepatoblastoma 29.1 HNF1A GPC3 CTNNB1 AFP
5 fibrolamellar carcinoma 29.1 GPC3 CTNNB1 AFP
6 teratoma 28.7 GPC3 CTNNB1 CDH1 AFP
7 hepatocellular carcinoma 27.3 SREBF1 SLCO1B3 HNF1A GSTP1 GPC3 GLUL
8 hepatic adenomas, familial 12.1
9 adenoma 11.1
10 mixed epithelial stromal tumour 10.4 CYP1B1 CYP1A2
11 vulvar intraepithelial neoplasia 10.4 CTNNB1 CDH1
12 goblet cell carcinoid 10.4 CTNNB1 CDH1
13 mammographic density 10.4 CYP1B1 CYP1A1
14 glycogen storage disease ia 10.4
15 acetaminophen metabolism 10.3 GSTP1 CYP1A2 CYP1A1
16 fatty liver disease, nonalcoholic 1 10.3
17 glycogen storage disease due to glucose-6-phosphatase deficiency 10.3
18 hyperbilirubinemia, rotor type 10.3 SLCO1B3 SLCO1B1
19 liver disease 10.2
20 colorectal adenoma 10.2 GSTP1 CTNNB1 CDH1
21 lynch syndrome 10.2 GSTP1 CYP1A1 CTNNB1 ASS1
22 familial adenomatous polyposis 10.1
23 amyloidosis 10.1
24 maturity-onset diabetes of the young 10.1
25 liver cirrhosis 10.1
26 fatty liver disease 10.1
27 amyloidosis aa 10.1
28 familial hyperlipidemia 10.1 SREBF1 SLC37A4 G6PC
29 intrahepatic cholestasis of pregnancy 10.1 SLCO1B3 SLCO1B1 CYP1A1
30 extragonadal nonseminomatous germ cell tumor 10.0 G6PC AFP
31 polycystic ovary syndrome 10.0
32 hemosiderosis 10.0
33 posttransplant acute limbic encephalitis 10.0
34 rare hereditary hemochromatosis 10.0
35 embryonal sarcoma 10.0 GPC3 CTNNB1
36 liver sarcoma 9.9 FABP1 AFP
37 fanconi anemia, complementation group a 9.9
38 body mass index quantitative trait locus 11 9.9
39 maturity-onset diabetes of the young, type 3 9.9
40 body mass index quantitative trait locus 9 9.9
41 body mass index quantitative trait locus 8 9.9
42 body mass index quantitative trait locus 4 9.9
43 body mass index quantitative trait locus 10 9.9
44 body mass index quantitative trait locus 7 9.9
45 body mass index quantitative trait locus 12 9.9
46 body mass index quantitative trait locus 14 9.9
47 beta-thalassemia 9.9
48 body mass index quantitative trait locus 18 9.9
49 body mass index quantitative trait locus 19 9.9
50 body mass index quantitative trait locus 20 9.9
51 non-alcoholic fatty liver disease 9.9
52 thalassemia 9.9
53 nephrotic syndrome 9.9
54 telangiectasis 9.9
55 diarrhea 9.9
56 cholestasis 9.9
57 vascular disease 9.9
58 hepatitis b 9.9
59 paraplegia 9.9
60 dentinogenesis imperfecta type 2 9.9
61 nodular regenerative hyperplasia 9.9
62 rare tumor 9.9
63 renal pelvis adenocarcinoma 9.9 CDH1 AFP
64 gastroschisis 9.9 CYP1A2 CYP1A1 AFP
65 tubular adenocarcinoma 9.8 CTNNB1 CDH1 AFP
66 fibrosis of extraocular muscles, congenital, 1 9.8
67 systemic lupus erythematosus 9.8
68 marfan syndrome 9.8
69 polykaryocytosis inducer 9.8
70 retinoblastoma 9.8
71 tetralogy of fallot 9.8
72 glycogen storage disease iii 9.8
73 glycogen storage disease iv 9.8
74 dubin-johnson syndrome 9.8
75 myelofibrosis 9.8
76 ocular motor apraxia 9.8
77 budd-chiari syndrome 9.8
78 abdominal obesity-metabolic syndrome 1 9.8
79 body mass index quantitative trait locus 1 9.8
80 aplastic anemia 9.8
81 cholangitis, primary sclerosing 9.8
82 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.8
83 leptin deficiency or dysfunction 9.8
84 carbonic anhydrase va deficiency, hyperammonemia due to 9.8
85 deficiency anemia 9.8
86 thrombosis 9.8
87 cryptococcal meningitis 9.8
88 non-alcoholic steatohepatitis 9.8
89 castleman disease 9.8
90 glucose intolerance 9.8
91 portal hypertension 9.8
92 hydronephrosis 9.8
93 hyperandrogenism 9.8
94 portal vein thrombosis 9.8
95 iron deficiency anemia 9.8
96 neutropenia 9.8
97 gender identity disorder 9.8
98 pancytopenia 9.8
99 leiomyoma 9.8
100 tuberous sclerosis 9.8
101 sclerosing cholangitis 9.8
102 islet cell tumor 9.8
103 viral hepatitis 9.8
104 myeloproliferative neoplasm 9.8
105 iron metabolism disease 9.8
106 hemangioma 9.8
107 tic disorder 9.8
108 endometriosis 9.8
109 adenocarcinoma 9.8
110 acute kidney failure 9.8
111 lipid metabolism disorder 9.8
112 myofibroma 9.8
113 bile duct cancer 9.8
114 familial retinoblastoma 9.8
115 infertility 9.8
116 hemoglobin e disease 9.8
117 lupus erythematosus 9.8
118 cholangitis 9.8
119 congenital hepatic fibrosis 9.8
120 banti's syndrome 9.8
121 congenital extrahepatic portosystemic shunt 9.8
122 inherited bone marrow failure syndromes 9.8
123 rosai-dorfman disease 9.8
124 unicentric castleman disease 9.8
125 chronic pain 9.8
126 seizure disorder 9.8
127 glycogen storage disease due to glycogen branching enzyme deficiency 9.8
128 bicornuate uterus 9.8
129 hepatoportal sclerosis 9.8
130 pik3ca-related overgrowth syndrome 9.8
131 acute liver failure 9.8
132 renal dysplasia 9.8
133 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.8
134 germ cell cancer 9.8 CYP1B1 CYP1A2 AFP
135 ovarian embryonal carcinoma 9.7 GPC3 AFP
136 ovarian primitive germ cell tumor 9.7 GPC3 AFP
137 simpson-golabi-behmel syndrome 9.7 GPC3 CTNNB1
138 ovarian endodermal sinus tumor 9.7 GPC3 AFP
139 ovarian wilms' cancer 9.7 GPC3 AFP
140 testicular malignant germ cell cancer 9.6 GPC3 AFP
141 ovarian gonadoblastoma 9.6 GPC3 AFP
142 sclerosing hepatic carcinoma 9.6 GPC3 AFP
143 sarcomatous intrahepatic cholangiocarcinoma 9.5 GPC3 AFP
144 bile duct adenocarcinoma 9.4 GPC3 CDH1 AFP
145 testicular yolk sac tumor 9.4 GPC3 AFP
146 gastric adenocarcinoma 9.4 IL11 GSTP1 CTNNB1 CDH1 AFP
147 mixed cell type cancer 9.4 GPC3 CTNNB1 CDH1 AFP
148 intrahepatic cholangiocarcinoma 9.4 GPC3 CTNNB1 CDH1 AFP
149 cholangiocarcinoma 9.4 GPC3 CTNNB1 CDH1 AFP
150 hepatoid adenocarcinoma 9.3 GPC3 AFP
151 wilms tumor 1 9.2 GPC3 CTNNB1 CDH1 AFP
152 liver benign neoplasm 8.3 SLC37A4 IL6ST HNF1A GSTP1 GPC3 GLUL

Graphical network of the top 20 diseases related to Hepatocellular Adenoma:



Diseases related to Hepatocellular Adenoma

Symptoms & Phenotypes for Hepatocellular Adenoma

MGI Mouse Phenotypes related to Hepatocellular Adenoma:

45 (showing 4, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.16 AFP ASS1 CDH1 CTNNB1 CYP1A1 CYP1A2
2 liver/biliary system MP:0005370 9.93 AFP CTNNB1 CYP1A1 CYP1A2 FABP1 G6PC
3 mortality/aging MP:0010768 9.8 AFP ASS1 CDH1 CTNNB1 CYP1A1 CYP1A2
4 neoplasm MP:0002006 9.17 AFP CDH1 CTNNB1 CYP1A2 CYP1B1 G6PC

Drugs & Therapeutics for Hepatocellular Adenoma

Drugs for Hepatocellular Adenoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 2, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Liver Extracts
2 Hematinics

Interventional clinical trials:

(showing 2, show less)
# Name Status NCT ID Phase Drugs
1 Selective Internal Radiation Therapy for Hepatocellular Carcinomas With Yttrium-90 Loaded Microspheres: Optimized Dosimetry Versus Standard Dosimetry Completed NCT02582034 Phase 2
2 Preoperative Evaluation of the Remaining Part of the Liver for Liver Resection Not yet recruiting NCT04100304

Search NIH Clinical Center for Hepatocellular Adenoma

Genetic Tests for Hepatocellular Adenoma

Anatomical Context for Hepatocellular Adenoma

The Foundational Model of Anatomy Ontology organs/tissues related to Hepatocellular Adenoma:

19
Liver Cells

MalaCards organs/tissues related to Hepatocellular Adenoma:

40
Liver, Bone, Bone Marrow, Ovary, Placenta, Skin, Brain

Publications for Hepatocellular Adenoma

Articles related to Hepatocellular Adenoma:

(showing 944, show less)
# Title Authors PMID Year
1
Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice. 54 61
19376605 2009
2
Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. 54 61
18803590 2009
3
Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions. 54 61
18976006 2008
4
Regressive liver adenomatosis following androgenic progestin therapy withdrawal: a case report with a 10-year follow-up and a molecular analysis. 54 61
17535860 2007
5
Genotype phenotype classification of hepatocellular adenoma. 54 61
17569132 2007
6
HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. 54 61
17379603 2007
7
Association of CYP1B1 germ line mutations with hepatocyte nuclear factor 1alpha-mutated hepatocellular adenoma. 54 61
17363580 2007
8
Hepatocellular adenoma displaying a HNF1alpha inactivation in a patient with familial adenomatous polyposis coli. 54 61
17049664 2006
9
Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver. 54 61
16606445 2006
10
Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. 54 61
16496320 2006
11
Distinct methylation patterns of benign and malignant liver tumors revealed by quantitative methylation profiling. 54 61
15897561 2005
12
Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli. 54 61
15287021 2004
13
Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. 54 61
12660822 2003
14
Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution. 54 61
9371521 1997
15
[Hepatocellular adenoma with a high level of alpha fetoprotein. Apropos of a case observed in the Central hospital of Yaoundé, Cameroon]. 54 61
1284392 1992
16
Reply to "Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia". 61
32022384 2020
17
Hepatocellular adenoma(s) arising in nodular regenerative hyperplasia in a patient with systemic lupus erythematosus. 61
31810588 2020
18
Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia. 61
31816064 2020
19
Management of patients with hepatocellular adenoma: a single-institution experience. 61
31943651 2020
20
Growth of hepatocellular adenoma during pregnancy: A prospective study. 61
31550458 2020
21
Performance of Contrast-Enhanced Sonography Versus MRI With a Liver-Specific Contrast Agent for Diagnosis of Hepatocellular Adenoma and Focal Nodular Hyperplasia. 61
31573852 2020
22
Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns. 61
32002637 2020
23
Activation of tumor-promoting pathways implicated in hepatocellular adenoma/carcinoma, a long-term complication of glycogen storage disease type Ia. 61
31735334 2020
24
Model to Predict Regression of Large-Size Hepatocellular Adenoma: More Information Needed. 61
31577569 2020
25
Large size and haemorrhage are not contraindications to laparoscopic resection of hepatocellular adenoma. 61
31983071 2020
26
Hyperintense Liver Masses at Hepatobiliary Phase Gadoxetic Acid-enhanced MRI: Imaging Appearances and Clinical Importance. 61
31834849 2020
27
Analysis of β-catenin gene mutations and gene expression in liver tumours of C57BL/10J mice produced by chronic administration of sodium phenobarbital. 61
31836555 2020
28
Diagnosis of Liver Neoplasms by Computational and Statistical Image Analysis. 61
31803308 2019
29
Radiological aspects of giant hepatocellular adenoma of the left liver: A case report. 61
31832416 2019
30
Multi-parameter ultrasound based on the logistic regression model in the differential diagnosis of hepatocellular adenoma and focal nodular hyperplasia. 61
31908724 2019
31
Adrenocortical Scintigraphy With SPECT/CT for the Diagnosis of Hepatic Adrenal Rest. 61
31789919 2019
32
Phenotype or Genotype: Decision-Making Dilemmas in Hepatocellular Adenoma. 61
31206716 2019
33
Diagnosis of hepatocellular adenoma in men before onset of diabetes in HNF1A-MODY: Watch out for winkers. 61
31483937 2019
34
Hepatocellular adenoma in Taiwan: Distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype. 61
31698521 2019
35
Primary hepatocellular adenoma due to biallelic HNF1A mutations and its co-occurrence with MODY 3: case-report and review of the literature. 61
31754975 2019
36
Genomic profiling of well-differentiated hepatocellular neoplasms with diffuse glutamine synthetase staining reveals similar genetics across the adenoma to carcinoma spectrum. 61
31189995 2019
37
Tomoelastography Distinguishes Noninvasively between Benign and Malignant Liver Lesions. 61
31551364 2019
38
The impact of hepatocyte nuclear factor-1α on liver malignancies and cell stemness with metabolic consequences. 61
31685031 2019
39
MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio. 61
30993437 2019
40
Unclassified hepatocellular adenoma expressing ASS1 associated with inflammatory hepatocellular adenomas. 61
31047837 2019
41
Enhancement pattern of hepatocellular adenoma (HCA) on MR imaging performed with Gd-EOB-DTPA versus other Gd-based contrast agents (GBCAs): An intraindividual comparison. 61
31437747 2019
42
Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon. 61
31570768 2019
43
Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma? 61
31533893 2019
44
Impact of open and minimally invasive resection of symptomatic solid benign liver tumours on symptoms and quality of life: a systematic review. 61
30926331 2019
45
Safety and efficacy of transarterial embolization of hepatocellular adenomas. 61
31313827 2019
46
Case of resected multiple hepatocellular adenomas in a young man with severe obesity. 61
31410698 2019
47
Development and Validation of a Model to Predict Regression of Large Size Hepatocellular Adenoma. 61
30920416 2019
48
Human hepatocellular adenoma as a promising cell source for bioartificial liver systems. 61
31316625 2019
49
A Proteomic Analysis of GSD-1a in Mouse Livers: Evidence for Metabolic Reprogramming, Inflammation, and Macrophage Polarization. 61
31173686 2019
50
[Exploration on laparoscopic hepatectomy on central liver tumor: a report of 40 cases]. 61
31269614 2019
51
Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience. 61
30306412 2019
52
[Hepatic adenoma with high phlogosis indices: what relationship? Description of a pediatric clinical case.] 61
31282486 2019
53
Inflammatory Hepatocellular Adenoma with Elevated Serum Protein Induced by Vitamin K Absence/Antagonist-II in Adult Males. 61
30799343 2019
54
The effect of oral contraceptive pill cessation on hepatocellular adenoma diameter: A retrospective cohort study. 61
30773766 2019
55
New MRI features improve subtype classification of hepatocellular adenoma. 61
30523457 2019
56
Molecular classification of hepatocellular adenoma: A single-center experience. 61
31225410 2019
57
Hepatocellular adenoma: An unsolved diagnostic enigma. 61
31171888 2019
58
Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage. 61
30637773 2019
59
Hepatic CYP1A2 activity in liver tumors and the implications for preoperative volume-function analysis. 61
30869529 2019
60
Evaluation of texture analysis for the differential diagnosis of focal nodular hyperplasia from hepatocellular adenoma on contrast-enhanced CT images. 61
30267107 2019
61
Malignant transformation of hepatocellular adenoma in a young female patient after ovulation induction fertility treatment: A case report. 61
31123560 2019
62
Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia. 61
30557050 2019
63
Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia. 61
30252977 2019
64
Utility of rapid on-site evaluation for needle core biopsies and fine-needle aspiration cytology done for diagnosis of mass lesions of the liver. 61
31287422 2019
65
Surgical indications for focal nodular hyperplasia of the liver: Single-center experience of 48 adult cases. 61
30863802 2019
66
Update on the pathology of liver neoplasms. 61
30597357 2019
67
Snapshot summary of diagnosis and management of hepatocellular adenoma subtypes. 61
30213653 2019
68
[Hepatocellular carcinomas and their mimics]. 61
30706100 2019
69
Molecular Pathological Differences in Global Gene Expression between Two Sustained Proliferative Lesions, Nodular Regenerative Hepatocellular Hyperplasia and Hepatocellular Adenoma, in Mice. 61
30572783 2019
70
OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy. 61
30218633 2019
71
Immunohistochemical Staining on an Excision Biopsy Specimen as a Diagnostic Modality for Rare Idiopathic Hepatocellular Adenoma: A Case Report. 61
31073109 2019
72
Inflammatory hepatocellular adenoma in a patient with Turner's syndrome: A case report. 61
30798096 2019
73
A difficult case of β-catenin-mutated hepatocellular adenoma: a lesson for diagnosis. 61
30184258 2019
74
Synchronous Unicentric Castleman Disease and Inflammatory Hepatocellular Adenoma: a Case Report. 61
31113603 2019
75
Ultrasound Imaging of Hepatocellular Adenoma Using the New Histology Classification. 61
30396597 2019
76
Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency. 61
31662921 2019
77
State-of-the-art MR Imaging of Fat-containing Focal Lesions of the Liver. 61
32008550 2019
78
Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA. 61
30121369 2019
79
[Contrast-enhanced ultrasound in differential diagnosis of focal liver lesions]. 61
31317941 2019
80
LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype. 61
31059558 2019
81
Diffusion Kurtosis MR Imaging versus Conventional Diffusion-Weighted Imaging for Distinguishing Hepatocellular Carcinoma from Benign Hepatic Nodules. 61
31396023 2019
82
Benign liver tumors 61
30869222 2018
83
Regression of hepatocellular adenoma after bariatric surgery in severe obese patients. 61
30025198 2018
84
Hemorrhage of hepatocellular adenoma: a complication that can be treated by conservative management without surgery. 61
31217088 2018
85
Clinicopathological investigation of steatohepatitic hepatocellular carcinoma: A multicenter study using immunohistochemical analysis of adenoma-related markers. 61
30058778 2018
86
Molecular biology and gene therapy for glycogen storage disease type Ib. 61
29663270 2018
87
Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors. 61
29630756 2018
88
Liver atoll sign: Inflammatory hepatocellular adenoma. 61
30309147 2018
89
Hepatocellular adenoma in a woman who was undergoing testosterone treatment for gender identity disorder. 61
29589251 2018
90
Laparoscopic liver resection for hemorrhagic hepatocellular adenoma in a pregnant patient. 61
28982300 2018
91
Spontaneous hemoperitoneum in pregnancy caused by a hepatocellular adenoma, accompanied by fetal death. 61
30082185 2018
92
Systemic AA Amyloidosis Caused by Inflammatory Hepatocellular Adenoma. 61
30231230 2018
93
Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomas. 61
29572896 2018
94
Ectopic Liver Within the Placental Parenchyma of a Stillborn Fetus. 61
28593805 2018
95
Correction to: Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful? 61
29230554 2018
96
Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful? 61
29110059 2018
97
Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumours. 61
29265678 2018
98
Atypical Hepatocellular Neoplasms: Review of Clinical, Morphologic, Immunohistochemical, Molecular, and Cytogenetic Features. 61
29649004 2018
99
Can point shear wave elastography differentiate focal nodular hyperplasia from hepatocellular adenoma. 61
29740826 2018
100
Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases. 61
29784585 2018
101
Hepatocellular Carcinoma Arising in a Huge Hepatocellular Adenoma with Bone Marrow Metaplasia. 61
29281780 2018
102
Hepatocellular nodules in vascular liver diseases. 61
29804132 2018
103
Hepatic angiomyolipoma: mutation analysis and immunohistochemical pitfalls in diagnosis. 61
29512829 2018
104
Retrospective Single-Arm Cohort Study of Patients with Hepatocellular Adenomas Treated with Percutaneous Thermal Ablation. 61
29417268 2018
105
Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice. 61
29545603 2018
106
Copper deposition in focal nodular hyperplasia and inflammatory hepatocellular adenoma. 61
29127141 2018
107
Growth of Focal Nodular Hyperplasia is Not a Reason for Surgical Intervention, but Patients Should be Referred to a Tertiary Referral Centre. 61
29167952 2018
108
Sirtuin signaling controls mitochondrial function in glycogen storage disease type Ia. 61
29740774 2018
109
Hepatic glucose-6-phosphatase-α deficiency leads to metabolic reprogramming in glycogen storage disease type Ia. 61
29545180 2018
110
EZH2 Expression in Naturally Occurring Canine Tumors. 61
29663940 2018
111
Quantitative analysis Of hepatocellular adenoma and focal nodular hyperplasia in the hepatobiliary phase: External validation of LLCER method using gadobenate dimeglumine as contrast agent. 61
28589549 2018
112
Response to "Quantitative analysis of hepatocellular adenoma and focal nodular hyperplasia in the hepatobiliary phase: External validation of llcer method using gadobenate dimeglumine as contrast agent". 61
28580722 2018
113
MR imaging of hepatocellular adenomas on genotype-phenotype classification: A report from China. 61
29496071 2018
114
[Benign liver tumours - current diagnostics and therapeutic modalities]. 61
29570181 2018
115
Visualization and quantification of dynamic STAT3 homodimerization in living cells using homoFluoppi. 61
29402895 2018
116
Unclassified hepatocellular adenoma in a middle-aged woman with glucose intolerance. 61
29116626 2018
117
A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma. 61
28726119 2018
118
Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing. 61
30052636 2018
119
Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist. 61
30519546 2018
120
Targeting hepatocarcinogenesis model in C56BL6 mice with pan-aurora kinase inhibitor Danusertib. 61
29581770 2018
121
Indications for liver surgery in benign tumours. 61
29875801 2018
122
Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas. 61
28618047 2017
123
Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk. 61
28646562 2017
124
Retrospective study on timing of resection of hepatocellular adenoma. 61
28857134 2017
125
Molecular classification of hepatocellular adenoma in clinical practice. 61
28733222 2017
126
Circulating D-dimer level correlates with disease characteristics in hepatoblastoma patients. 61
29381980 2017
127
Candidate genes responsible for early key events of phenobarbital-promoted mouse hepatocellular tumorigenesis based on differentiation of regulating genes between wild type mice and humanized chimeric mice. 61
30090543 2017
128
Liver-directed gene therapy for murine glycogen storage disease type Ib. 61
28973635 2017
129
Inflammatory and multiple hepatocellular adenoma are associated with a higher BMI. 61
28704224 2017
130
Screening the key genes of hepatocellular adenoma via microarray analysis of DNA expression and methylation profiles. 61
28943905 2017
131
Polymorphic multiple hepatocellular adenoma including a non-steatotic HNF1α-inactivated variant. 61
28992889 2017
132
Short-term outcomes of laparoscopic vs. open liver resection for hepatocellular adenoma: a multicenter propensity score adjustment analysis by the AFC-HCA-2013 study group. 61
28281121 2017
133
A Model-Based Prediction of the Probability of Hepatocellular Adenoma and Focal Nodular Hyperplasia Based on Characteristics on Contrast-Enhanced Ultrasound. 61
28743375 2017
134
Recent development and gene therapy for glycogen storage disease type Ia. 61
29576889 2017
135
Intravoxel incoherent motion and dynamic contrast-enhanced MRI for differentiation between hepatocellular adenoma and focal nodular hyperplasia. 61
28590780 2017
136
[Benign focal liver lesions: a clinical, radiological and pathological review]. 61
28853804 2017
137
Men with biopsy-confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: A nationwide population-based study. 61
28317318 2017
138
Management and outcome of hepatocellular adenoma with massive bleeding at presentation. 61
28740346 2017
139
Exome analysis of the evolutionary path of hepatocellular adenoma-carcinoma transition, vascular invasion and brain dissemination. 61
28323122 2017
140
Malignant potential of hepatocellular adenoma. 61
28635168 2017
141
Clinical correspondence to hepatocellular carcinoma-related lesions with atypical radiological pattern. 61
28626210 2017
142
The challenge of liver resection in benign solid liver tumors in modern times - in which cases should surgery be done? 61
28709169 2017
143
Systematic review of transarterial embolization for hepatocellular adenomas. 61
28518415 2017
144
Immunohistochemistry in the Diagnosis of Hepatocellular Carcinoma. 61
28506367 2017
145
Hepatocellular adenoma in a European flatfish (Limanda limanda): Genetic alterations in laser-capture micro-dissected tissue and global transcriptomic approach. 61
28473212 2017
146
Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens. 61
28087475 2017
147
Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy. 61
28334808 2017
148
Hepatocellular adenoma: imaging review of the various molecular subtypes. 61
28126185 2017
149
Hepatocellular adenoma among adult survivors of childhood and young adult cancer. 61
27781382 2017
150
Malignant transformation of a β-catenin inflammatory adenoma due to an S45 β-catenin-activating mutation present 12 years before. 61
27984126 2017
151
Distinction between inflammatory hepatocellular adenoma and mass effect on liver sampling. 61
27989788 2017
152
Systematic review: benefits and harms of transarterial embolisation for treating hepatocellular adenoma. 61
28318052 2017
153
Hepatocellular adenoma: Classification, variants and clinical relevance. 61
28131467 2017
154
hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma. 61
28321157 2017
155
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation. 61
27939373 2017
156
Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors. 61
28096054 2017
157
A Clinicopathological Study of Paediatric Liver Tumours in a Tertiary Care Hospital. 61
28511396 2017
158
Hepatotoxicity associated with illicit use of anabolic androgenic steroids in doping. 61
28379599 2017
159
Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions. 61
27903597 2017
160
Giant hepatocellular carcinoma with bone metastasis in a young adult, emerged from pigmented adenoma with beta-Catenin activation: A case report. 61
28505585 2017
161
Tissue Biomarkers in Hepatocellular Tumors: Which, When, and How. 61
28280721 2017
162
Diagnostic Value of Gadoxetic Acid-Enhanced MR Imaging to Distinguish HCA and Its Subtype from FNH: A Systematic Review. 61
28824299 2017
163
Markers of Hippo-Pathway Activity in Tumor Forming Liver Lesions. 61
27276915 2017
164
Background data on NOD/Shi-scid IL-2Rγnull mice (NOG mice). 61
29142168 2017
165
Malignant Transformation of Hepatocellular Adenoma. 61
27988517 2017
166
Non-alcoholic steatohepatitis-associated hepatic fibrosis and hepatocellular carcinoma in a combined mouse model of genetic modification and dietary challenge. 61
26992446 2017
167
Diagnostic Value of Gd-EOB-DTPA-MRI for Hepatocellular Adenoma: A Meta-Analysis. 61
28607606 2017
168
Hepatocellular adenoma with severe fatty change in a male Spontaneously Diabetic Torii rat. 61
28190927 2017
169
Hepatic adenomatosis in liver cirrhosis. 61
28932768 2017
170
Comparison of Subtypes of Hepatocellular Adenoma to Hepatocellular Carcinoma and Non-Neoplastic Liver Tissue in Terms of PTEN Expression. 61
29687774 2017
171
Expression of c-MET Protein in Various Subtypes of Hepatocellular Adenoma Compared to Hepatocellular Carcinoma and Non-Neoplastic Liver in Human Tissue. 61
29256857 2017
172
Imaging of Hepatic Focal Nodular Hyperplasia: Pictorial Review and Diagnostic Strategy. 61
27986170 2016
173
Touch cytology smear of an inflammatory hepatocellular adenoma displaying an unusual pattern: A case report. 61
27434199 2016
174
Evidence of good prognosis of hepatocellular adenoma in post-menopausal women. 61
27524464 2016
175
Use of a Machine-learning Method for Predicting Highly Cited Articles Within General Radiology Journals. 61
27692588 2016
176
Benign Hepatocellular Nodules: Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging Based on Molecular Background. 61
27740898 2016
177
Long-term outcomes of resection in patients with symptomatic benign liver tumours. 61
27553837 2016
178
Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia. 61
26969817 2016
179
Myxoid hepatocellular neoplasms: imaging appearance of a unique mucinous tumor variant. 61
27334021 2016
180
Hepatocellular adenoma: when and how to treat? Update of current evidence. 61
27803743 2016
181
Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma. 61
27469330 2016
182
Malignant transformation of hepatocellular adenoma with bone marrow metaplasia arising in glycogen storage disease type I: A case report. 61
27900094 2016
183
Hepatocellular Adenoma of the Placenta With Updated Immunohistochemical and Molecular Markers: A Case Report. 61
27106781 2016
184
European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group. 61
27593592 2016
185
Contrast-enhanced ultrasonographic findings of serum amyloid A-positive hepatocellular neoplasm: Does hepatocellular adenoma arise in cirrhotic liver? 61
27660679 2016
186
The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models. 61
27669229 2016
187
Hepatocellular adenoma with malignant transformation in a patient with neonatal portal vein thrombosis. 61
27042773 2016
188
Two-Step Forward Genetic Screen in Mice Identifies Ral GTPase-Activating Proteins as Suppressors of Hepatocellular Carcinoma. 61
27178121 2016
189
 Pigmented hepatocellular adenoma with β-catenin activation: case report and literature review. 61
27236161 2016
190
Pigmented hepatocellular adenoma with β-catenin activation: case report and literature review. 61
31227120 2016
191
Hepatoblastoma Arising in a Pigmented β-catenin-activated Hepatocellular Adenoma: Case Report and Review of the Literature. 61
27096257 2016
192
Multiple β-catenin mutations in hepatocellular lesions arising in Abernethy malformation. 61
27038679 2016
193
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma. 61
27383300 2016
194
Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice. 61
26838046 2016
195
Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma. 61
27189732 2016
196
C3H/He Mice as an Incompatible Cholangiocarcinoma Model by Clonorchis sinensis, Dicyclanil and N-Nitrosodimethylamine. 61
27417082 2016
197
Expression of liver fatty acid binding protein in hepatocellular carcinoma. 61
26997447 2016
198
A Rare Case of Haemoperitoneum in Pregnancy. 61
27190818 2016
199
Qualitative and Quantitative Gadoxetic Acid-enhanced MR Imaging Helps Subtype Hepatocellular Adenomas. 61
26505921 2016
200
Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model. 61
26471504 2016
201
Review of genotoxicity and rat carcinogenicity investigations with astaxanthin. 61
26713891 2016
202
Reappraisal of the Role of Portacaval Shunting in the Growth of Patients With Glycogen Storage Disease Type I in the Era of Liver Transplantation. 61
26360666 2016
203
Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging. 61
26070500 2016
204
Outcomes of liver resection for haemorrhagic hepatocellular adenoma. 61
26805568 2016
205
Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis. 61
26961851 2016
206
Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma. 61
26769138 2016
207
Ultrasound features of hepatocellular adenoma and the additional value of contrast-enhanced ultrasound. 61
26818543 2016
208
Fenofibrate-induced massive regression of mutiple inflammatory hepatocellular adenoma. 61
26572747 2016
209
TERT promoter mutations in primary liver tumors. 61
26336998 2016
210
PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions. 61
26776850 2016
211
Development of a conditional liver tumor model by mifepristone-inducible Cre recombination to control oncogenic kras V12 expression in transgenic zebrafish. 61
26790949 2016
212
Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats. 61
26548419 2016
213
Epithelioid angiomyolipoma of the liver: Clinicopathological correlation in a series of 4 cases. 61
26765232 2016
214
The management of hepatocellular adenoma in obese patients: issues to consider. 61
26386199 2016
215
Hepatocellular adenoma: comparison between real-time contrast-enhanced ultrasound and dynamic computed tomography. 61
27386395 2016
216
Response to 'The management of hepatocellular adenoma in obese patients: issues to consider'. 61
26767571 2016
217
[Diagnostics and treatment of hepatocellular adenomas]. 61
27650020 2016
218
Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis. 61
26516697 2016
219
What to do when I find a focal lesion in the liver? 61
29188948 2016
220
NF-κB/RelA and Nrf2 cooperate to maintain hepatocyte integrity and to prevent development of hepatocellular adenoma. 61
26348541 2016
221
Gd-EOB-DTPA-Enhanced Magnetic Resonance Findings of a Giant Inflammatory Hepatocellular Adenoma: a Case Report and Review of the Literature. 61
25894634 2015
222
A case of inflammatory hepatocellular adenoma displaying an unusual histological pattern. 61
26589902 2015
223
Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging-A Systematic Review. 61
26599935 2015
224
Unique genetic alterations and clinicopathological features of hepatocellular adenoma in Chinese population. 61
26608415 2015
225
Hepatic angiomyolipoma: differential diagnosis from other liver tumors in a special reference to vascular imaging - importance of early drainage vein. 61
26943379 2015
226
Diagnosis and treatment of benign liver nodules: Brazilian Society of Hepatology (SBH) recommendations. 61
26959805 2015
227
Outcome after a liver resection of benign lesions. 61
26456947 2015
228
Focal nodular hyperplasia and hepatocellular adenoma: The value of shear wave elastography for differential diagnosis. 61
26299323 2015
229
LATE SURGICAL TREATMENT FOR SPONTANEOUS RUPTURE OF HEPATOCELLULAR ADENOMA: CASE REPORT. 61
26734808 2015
230
Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging--A Systematic Review. 61
26020440 2015
231
Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI. 61
25851028 2015
232
Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders. 61
26119687 2015
233
Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in mice. 61
26560698 2015
234
Hepatocellular adenoma: An update. 61
26557953 2015
235
Will weight loss become a future treatment of hepatocellular adenoma in obese patients? 61
26216699 2015
236
Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid-enhanced MR Imaging. 61
25985059 2015
237
Preserved or enhanced OATP1B3 expression in hepatocellular adenoma subtypes with nuclear accumulation of β-catenin. 61
25418671 2015
238
PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions. 61
26472264 2015
239
Pigmented hepatocellular adenomas have a high risk of atypia and malignancy. 61
26205181 2015
240
Simultaneous occurrence of focal nodular hyperplasia and HNF1A-inactivated hepatocellular adenoma: a collision tumor simulating a composite FNH-HCA. 61
26274031 2015
241
Current Proceedings in the Molecular Dissection of Hepatocellular Adenomas: Review and Hands-on Guide for Diagnosis. 61
26404250 2015
242
Serum Amyloid A-Positive Hepatocellular Neoplasm: A New Type of Tumor Arising in Patients with Advanced Alcoholic Disease. 61
26398230 2015
243
The Evolving Role of Nonalcoholic Fatty Liver Disease in Hepatic Neoplasia: Inflammatory Hepatocellular Adenoma in a Man with Metabolic Syndrome. 61
26378649 2015
244
Percutaneous Irreversible Electroporation of a Large Centrally Located Hepatocellular Adenoma in a Woman with a Pregnancy Wish. 61
25537309 2015
245
A case of β-catenin-positive hepatocellular adenoma with MR imaging sign of diffuse intratumoral fat deposition. 61
25875860 2015
246
Central element in liver masses, helpful, or pitfall? 61
25532744 2015
247
Management of Hepatocellular Adenoma: Recent Advances. 61
24909909 2015
248
Multiple liver lesions in a patient with Budd-Chiari syndrome secondary to polycythemia vera. 61
26019042 2015
249
Benign liver tumors in pediatric patients - Review with emphasis on imaging features. 61
26229397 2015
250
Giant hepatocellular adenoma in a previously obese thirteen-year-old boy. 61
26019045 2015
251
Giant hepatocellular adenoma with peliosis hepatis in a child: A diagnostic dilemma. 61
27522744 2015
252
Minimal hepatic glucose-6-phosphatase-α activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia. 61
26937391 2015
253
Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma. 61
25790815 2015
254
A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumors. 61
25448011 2015
255
Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report. 61
25986067 2015
256
Histopathological assessment of liver and gonad pathology in continental slope fish from the northeast Atlantic Ocean. 61
25756900 2015
257
Diagnosis of liver nodules within and outside screening programs. 61
25864209 2015
258
Hepatocellular adenoma with malignant transformation in male patients with non-cirrhotic livers. 61
26058379 2015
259
[A case report of overlapping Rosai-Dorfman disease of the liver and gallbladder combined with hepatocellular adenoma]. 61
26427072 2015
260
Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma. 61
25701530 2015
261
The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis. 61
25537979 2015
262
Hepatocellular adenoma management: advances but still a long way to go. 61
30190996 2015
263
Case of cholangiocellular carcinoma in a patient with glycogen storage disease type Ia. 61
24905794 2015
264
Hepatocellular adenoma management: call for shared guidelines and multidisciplinary approach. 61
25434466 2015
265
Two-year carcinogenicity study in rats with a nonnucleoside reverse transcriptase inhibitor. 61
25122632 2015
266
Malignant transformation of hepatocellular adenoma: how frequently does it happen? 61
26020024 2015
267
[Hepatocellular adenoma - new classification and recommendations]. 61
25786843 2015
268
[Focal nodular hyperplasia and hepatocellular adenoma]. 61
25575723 2015
269
Recreational Anabolic-Androgenic Steroid Use Associated With Liver Injuries Among Brazilian Young Men. 61
26549387 2015
270
[Hepatocyte nuclear factor 1α-inactivated hepatocellular adenomatosis in a patient with maturity-onset diabetes of the young type 3: case report and literature review]. 61
26346360 2015
271
Malignant Transformation of Hepatic Adenoma in Glycogen Storage Disease Type-1a: Report of an Exceptional Case Diagnosed on Surveillance Imaging. 61
26430540 2015
272
Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival. 61
26473022 2015
273
Diagnosis of Hepatic Angiomyolipoma by Combination of Baseline and Contrast-Enhanced Ultrasound--A Prospective Study in Non-Cirrhotic Patients. 61
26147859 2015
274
Differentiation of focal nodular hyperplasia from hepatocellular adenomas with low-mechanical-index contrast-enhanced sonography (CEUS): effect of size on diagnostic confidence. 61
25120205 2015
275
The N-nitrosodiethylamine mouse model: sketching a timeline of evolution of chemically-induced hepatic lesions. 61
25503129 2014
276
Imaging of benign hepatocellular lesions: current concepts and recent updates. 61
24636468 2014
277
Frequency of TERT promoter mutations in primary tumors of the liver. 61
25267585 2014
278
Polycystic ovary syndrome as a rare association with inflammatory hepatocellular adenoma: a case report. 61
24994518 2014
279
Hepatocellular adenoma showing high uptake of (18)F-fluorodeoxyglucose (FDG) via an increased expression of glucose transporter 2 (GLUT-2). 61
25034402 2014
280
Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor. 61
24743216 2014
281
Pure laparoscopic right hepatectomy with the hanging maneuver for multiple hepatocellular adenomas. 61
24871780 2014
282
Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI. 61
25055198 2014
283
Glutamine synthetase interpretation in hepatocellular adenoma. 61
25216583 2014
284
Malignant transformation of hepatocellular adenoma. 61
30190977 2014
285
Focal nodular hyperplasia-like lesion of the liver with focal adenoma features associated with idiopathic portal hypertension. 61
24397430 2014
286
ACG clinical guideline: the diagnosis and management of focal liver lesions. 61
25135008 2014
287
Open and laparoscopic resection of hepatocellular adenoma: trends over 23 years at a specialist hepatobiliary unit. 61
24852081 2014
288
Malignant transformation of hepatocellular adenoma over a decade. 61
25246462 2014
289
Resection, transplantation and local regional therapies for liver adenomas. 61
24957321 2014
290
Deregulation of RB1 expression by loss of imprinting in human hepatocellular carcinoma. 61
24838394 2014
291
Phenobarbital-mediated tumor promotion in transgenic mice with humanized CAR and PXR. 61
24863967 2014
292
Pictures of focal nodular hyperplasia and hepatocellular adenomas. 61
25232451 2014
293
Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers. 61
24129885 2014
294
Diffuse glutamine synthetase overexpression restricted to areas of peliosis in a β-catenin-activated hepatocellular adenoma: a potential pitfall in glutamine synthetase interpretation. 61
24997695 2014
295
β-Catenin activated hepatocellular adenoma: a report of three cases in Korea. 61
25071913 2014
296
[Study on the morphological features, pathologic diagnosis and differential diagnosis of well-differentiated hepatocellular carcinoma]. 61
25327795 2014
297
Hepatocellular adenoma: different entities for a single lesion. 61
24927616 2014
298
A retrospective histopathological survey on canine and feline liver diseases at the University of Tokyo between 2006 and 2012. 61
24717415 2014
299
Synthesis and evaluation of (18)F-labeled bile acid compound: a potential PET imaging agent for FXR-related diseases. 61
24776092 2014
300
Cytokeratin 7/19 expression in N-diethylnitrosamine-induced mouse hepatocellular lesions: implications for histogenesis. 61
24730441 2014
301
[Molecular classification of hepatocellular adenoma and its clinical significance]. 61
25209000 2014
302
Risk factors for bleeding in hepatocellular adenoma. 61
24760723 2014
303
Immunohistochemical pitfalls in the diagnosis of focal nodular hyperplasia and inflammatory hepatocellular adenoma. 61
24525010 2014
304
Genotype-phenotype correlations in hepatocellular adenoma: an update of MRI findings. 61
24509184 2014
305
Consequences of the disease-related L78R mutation for dimerization and activity of STAT3. 61
24569879 2014
306
Coexistence of inflammatory hepatocellular adenomas with HNF1α-inactivated adenomas: is there an association? 61
24236804 2014
307
Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up. 61
24746201 2014
308
Hepatocellular adenomatosis: what should the term stand for! 61
24126236 2014
309
Strangulated adenoma of the liver: a unique cause of acute abdomen. 61
25475531 2014
310
Indeterminate solid hepatic lesions identified on non-diagnostic contrast-enhanced computed tomography: assessment of the additional diagnostic value of contrast-enhanced ultrasound in the non-cirrhotic liver. 61
24387826 2014
311
Giant hepatocellular adenoma in a child. 61
24075794 2014
312
Noncirrhotic hepatocellular carcinoma: derivation from hepatocellular adenoma? Clinicopathologic analysis. 61
24051694 2014
313
The impact of obesity on liver histology. 61
24274863 2014
314
Outcomes of liver resection in hepatocellular adenoma and focal nodular hyperplasia. 61
23509949 2014
315
Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma. 61
23807780 2014
316
A family with a novel termination mutation in hepatic nuclear factor 1α in maturity-onset diabetes of the young type 3 which is unresponsive to sulphonylurea therapy. 61
24642958 2014
317
Interest of contrast-enhanced sonography to identify focal nodular hyperplasia with sinusoidal dilatation. 61
24139183 2014
318
Oncogenic deletion mutants of gp130 signal from intracellular compartments. 61
24213527 2014
319
Pathological diagnosis of benign hepatocellular nodular lesions based on the new World Health Organization classification. 61
25427732 2014
320
The predictive value of Golgi protein 73 in differentiating benign from malignant liver tumors. 61
25033446 2014
321
Contrast enhanced ultrasound (CEUS) characterization of grey-scale sonographic indeterminate focal liver lesions in pediatric practice. 61
24132647 2013
322
Minimally invasive treatment of hepatic adenoma in special cases. 61
24488396 2013
323
Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma. 61
24501689 2013
324
Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure. 61
24113455 2013
325
Spontaneous hepatocellular adenoma in paediatric age group - case report. 61
24551691 2013
326
Successful treatment of multiple hepatocellular adenomas with percutaneous radiofrequency ablation. 61
24259982 2013
327
Serum amyloid A-positive hepatocellular neoplasms in the resected livers from 3 patients with alcoholic cirrhosis. 61
23690168 2013
328
Toxicology and Carcinogenesis Studies of Mixtures of 3'-Azido-3'-Deoxythymidine (AZT), Lamivudine (3TC), and Nevirapine (NVP) (CAS Nos. 30516-87-1, 134678-17-4, 129618-40-2) in Genetically Modified C3B6.129F1-Trp53(tm1Brd) N12 Haploinsufficient Mice (in utero and postnatal gavage studies). 61
24503698 2013
329
Toxicology and carcinogenesis of 3´-azido-3´-deoxythymidine (AZT) (CAS No. 30516-87-1) in genetically modified C3B6.129F1-Trp53(tm1Brd) N12 haploinsufficient mice (in utero and postnatal gavage studies). 61
24503641 2013
330
Clinicopathological analysis of hepatocellular adenoma according to new bordeaux classification: report of eight korean cases. 61
24255628 2013
331
Esophageal adenocarcinoma in a 53-year-old mata mata turtle (Chelus fimbriatus). 61
24063112 2013
332
Living related liver transplantation in an adult patient with hepatocellular adenoma and carcinoma 13 years after bone marrow transplantation for Fanconi anemia: A case report. 61
23675868 2013
333
Benign hepatocellular nodules: what have we learned using the patho-molecular classification. 61
23876350 2013
334
Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker. 61
23364900 2013
335
Hepatocellular carcinoma arising in a telangiectatic hepatocellular adenoma. 61
23813141 2013
336
Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan. 61
23885159 2013
337
Congenital portosystemic shunts associated with liver tumours. 61
23537576 2013
338
Rupture of a hepatic adenoma in a young woman after an abdominal trauma: a case report. 61
23885157 2013
339
β-catenin activated hepatocellular adenoma. 61
23837144 2013
340
[Immunophenotypic classification of 3 cases of hepatocellular adenoma. Differential diagnosis with focal nodular hyperplasia]. 61
23664829 2013
341
Magnetic resonance of the liver with hepato-specific contrast: initial clinical experience in Brazil. 61
23912373 2013
342
Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas. 61
23084586 2013
343
Focal nodular hyperplasia and hepatocellular adenoma: current views. 61
24941710 2013
344
Hepatocellular benign tumors-from molecular classification to personalized clinical care. 61
23485860 2013
345
The effects of long-term exposure to ozokerite mainly consisting of an aliphatic series of hydrocarbons using F344 rats. 61
23380203 2013
346
Telangiectatic hyperplastic nodule associated with vascular malformation in a patient with chronic hepatitis B: radiologic and pathologic features. 61
23749674 2013
347
Laparoscopic bisegmentectomy 6 and 7 using a Glissonian approach and a half-Pringle maneuver. 61
23389058 2013
348
A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors. 61
23038063 2013
349
gp130 activation is regulated by D2-D3 interdomain connectivity. 61
23294003 2013
350
Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies). 61
23652021 2013
351
Management of hepatocellular adenoma: comparison of resection, embolization and observation. 61
23374365 2013
352
Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma. 61
22914605 2013
353
The use of 18F-fluoromethylcholine PET/CT in differentiating focal nodular hyperplasia from hepatocellular adenoma: a prospective study of diagnostic accuracy. 61
23154640 2013
354
Value and limits of routine histology alone or combined with glutamine synthetase immunostaining in the diagnosis of hepatocellular adenoma subtypes on surgical specimens. 61
23509631 2013
355
Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification. 61
23691331 2013
356
Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. 61
23509632 2013
357
Benign hepatocellular tumors in children: focal nodular hyperplasia and hepatocellular adenoma. 61
23555058 2013
358
Findings in Historical Control Harlan RCCHanTM: WIST Rats from 4-, 13-, 26-Week Studies. 61
23033222 2013
359
Histological and immunohistochemical revision of hepatocellular adenomas: a learning experience. 61
23533787 2013
360
MR Imaging of Hepatocellular Adenomas and Differential Diagnosis Dilemma. 61
23606972 2013
361
Evaluation of liver tumors using acoustic radiation force impulse elastography and correlation with histologic data. 61
23269717 2013
362
A serum amyloid A-positive hepatocellular neoplasm arising in alcoholic cirrhosis: a previously unrecognized type of inflammatory hepatocellular tumor. 61
22766792 2012
363
Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging. 61
23096201 2012
364
Adeno-associated virus gene therapy prevents hepatocellular adenoma in murine model of glycogen storage disease type Ia. 61
22706804 2012
365
Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8. 61
22911100 2012
366
Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes. 61
23060349 2012
367
Hepatocellular adenoma as a risk factor for hepatocellular carcinoma in a non-cirrhotic liver: a plea against. 61
22535376 2012
368
Co-existence of hepatocellular adenoma and focal nodular hyperplasia in a young female. 61
23293718 2012
369
Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy. 61
22422504 2012
370
Hepatocellular adenoma associated with familial adenomatous polyposis coli. 61
23293720 2012
371
Tumorigenicity of acrylamide and its metabolite glycidamide in the neonatal mouse bioassay. 61
22336951 2012
372
[Focal liver lesion, incidental finding]. 61
23033169 2012
373
Pigmented hepatocellular adenoma with complete CD34 immunostaining pattern: a diagnostic dilemma. 61
23455796 2012
374
Comparative histomorphological review of rat and human hepatocellular proliferative lesions. 61
22988337 2012
375
Toxicology and carcinogenesis studies of N,N-dimethyl-p-toluidine (CAS No. 99-97-8) in F344/N rats and B6C3F1/N mice (gavage studies). 61
23027199 2012
376
Hepatocellular adenoma subtypes: the impact of overweight and obesity. 61
22429502 2012
377
Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings. 61
22826395 2012
378
A retrospective study of tumours in black-tailed prairie dogs (Cynomys ludovicianus) submitted to a zoological pathology service. 61
22424809 2012
379
Liver tumor characterization--comments and illustrations regarding guidelines. 61
22723025 2012
380
Systematic review of haemorrhage and rupture of hepatocellular adenomas. 61
22619025 2012
381
Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. 61
22733890 2012
382
Hepatocellular adenoma associated with long-term exposure to phenobarbital: a paediatric case report. 61
22124572 2012
383
Hepatocellular adenoma: an excellent indication for laparoscopic liver resection. 61
22568415 2012
384
Case of telangiectatic/inflammatory hepatocellular adenoma arising in a patient with primary sclerosing cholangitis. 61
22568458 2012
385
Pregnancy and liver adenoma management: PALM-study. 61
22748109 2012
386
CT characteristics of primary hepatic mass lesions in dogs. 61
22244075 2012
387
Hepatocellular adenoma in glycogen storage disorder type I: a clinicopathological and molecular study. 61
22372484 2012
388
Hepatocellular carcinoma arising from hepatocellular adenoma in a hepatitis B virus-associated cirrhotic liver. 61
22079485 2012
389
Hepatocellular adenoma: a rare benign tumor of the liver. 61
22472417 2012
390
Constitutively active mutant gp130 receptor protein from inflammatory hepatocellular adenoma is inhibited by an anti-gp130 antibody that specifically neutralizes interleukin 11 signaling. 61
22523320 2012
391
Toxicology and carcinogenesis studies of kava kava extract (CAS No. 9000-38-8) in F344/N rats and B6C3F1 mice (Gavage Studies). 61
22441424 2012
392
Lack of associations between ultrasonographic appearance of parenchymal lesions of the canine liver and histological diagnosis. 61
22931398 2012
393
Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARα and CAR/PXR. 61
22245121 2012
394
Monitoring Cyp2b10 mRNA expression at cessation of 2-year carcinogenesis bioassay in mouse liver provides evidence for a carcinogenic mechanism devoid of human relevance: the dalcetrapib experience. 61
22293087 2012
395
Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats. 61
22266392 2012
396
Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. 61
22282184 2012
397
Overview of hepatocellular adenoma in Japan. 61
22973519 2012
398
[Giant haemangioma of the liver: diagnosis and treatment]. 61
22853763 2012
399
Liver-specific contrast agent-enhanced magnetic resonance and ¹⁸F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case. 61
22160355 2012
400
[Hepatocellular adenomas and pregnancy]. 61
22992247 2012
401
Hepatocellular adenoma: evaluation with contrast-enhanced ultrasound and MRI and correlation with pathologic and phenotypic classification in 26 lesions. 61
22811588 2012
402
The management of pregnancy in women with hepatocellular adenoma: a plea for an individualized approach. 61
23320183 2012
403
How normal is the liver in which the inflammatory type hepatocellular adenoma develops? 61
23024866 2012
404
Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI. 61
22194486 2012
405
Indications and long-term outcome after elective surgery for hepatocellular adenoma. 61
22273320 2012
406
Can a decision-making model be justified in the management of hepatocellular adenoma? 61
22098685 2012
407
GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. 61
21835143 2012
408
Development of hepatocellular carcinoma associated with anabolic androgenic steroid abuse in a young bodybuilder: a case report. 61
22934212 2012
409
Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus. 61
21562593 2012
410
"Incidentaloma" of the liver: management of a diagnostic and therapeutic dilemma. 61
22927707 2012
411
PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs. 61
23024649 2012
412
[Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma]. 61
22849944 2011
413
Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques. 61
21993269 2011
414
Liver toxicity and carcinogenicity in F344/N rats and B6C3F1 mice exposed to Kava Kava. 61
21871523 2011
415
DNA methylation in liver tumorigenesis in fish from the environment. 61
22048251 2011
416
Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. 61
21875850 2011
417
Characterization of hepatocellular adenoma based on the phenotypic classification: The Kanazawa experience. 61
21883740 2011
418
Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: role, controversies and approach to diagnosis. 61
21762411 2011
419
Hepatocellular adenoma containing hepatocellular carcinoma in a male patient with familial adenomatous polyposis coli: Report of a case. 61
21922375 2011
420
Natural history of hepatocellular adenoma formation in glycogen storage disease type I. 61
21481415 2011
421
Clinical features and natural history of hepatocellular adenomas: the impact of obesity. 61
21762186 2011
422
Toxicology and carcinogenesis studies of pulegone (CAS No. 89-82-7) in F344/N rats and B6C3F1 mice (gavage studies). 61
21921962 2011
423
Dose-related induction of hepatic preneoplastic lesions by diethylnitrosamine in C57BL/6 mice. 61
21628716 2011
424
EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies. 61
21330577 2011
425
Laparoscopic liver resection for hepatocellular adenoma. 61
21860698 2011
426
New monoallelic (partial tandem duplication) mutation of HNF1a gene in steatotic hepatocellular adenoma. 61
21566527 2011
427
Safety and efficacy of radiofrequency ablation for hepatocellular adenoma. 61
21616431 2011
428
[Hepatocellular adenoma treated with radiofrequency ablation in young male]. 61
21694493 2011
429
Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature. 61
21572265 2011
430
Pigmented hepatocellular adenoma: report of a case. 61
21626342 2011
431
Long-term ethanol consumption promotes hepatic tumorigenesis but impairs normal hepatocyte proliferation in rats. 61
21490289 2011
432
A pictorial review of benign hepatocellular nodular lesions: comprehensive radiological assessment incorporating the concept of anomalous portal tract syndrome. 61
21103893 2011
433
Toxicology and carcinogenesis studies of milk thistle extract (CAS No. 84604-20-6) in F344/N rats and B6C3F1 mice (Feed Studies). 61
21685957 2011
434
Evaluation of tumour markers as differential diagnostic tool in patients with suspicion of liver metastases from breast cancer. 61
21508401 2011
435
Molecular pathology of hepatic neoplasms: classification and clinical significance. 61
21559202 2011
436
[Prague Hepatology Meeting 2010--hepatopathology news]. 61
21604434 2011
437
Hepatocellular adenoma in men: a rare cause for liver resection. 61
21375862 2011
438
Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET/CT. 61
20717825 2011
439
Management of hepatocellular adenoma during pregnancy. 61
21094555 2011
440
Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management. 61
21339346 2011
441
Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. 61
21344354 2011
442
Chronic administration of ethanol leads to an increased incidence of hepatocellular adenoma by promoting H-ras-mutated cells. 61
21168264 2011
443
Management of liver adenomatosis by radiofrequency ablation. 61
21540605 2011
444
Changing trends in malignant transformation of hepatocellular adenoma. 61
21148580 2011
445
Systematic review of hepatocellular adenoma in China and other regions. 61
21175790 2011
446
Gd-EOB-DTPA-enhanced MR imaging findings of hepatocellular adenoma: correlation with pathological findings. 61
22214909 2011
447
[Hepatocellular adenoma. Answer to December e-quid]. 61
21352735 2011
448
[Expression and clinicopathologic significance of GPC3 and other antibodies in well-differentiated hepatocellular carcinoma]. 61
21429352 2011
449
General evaluation of hepatectomy and hepatocellular carcinoma cases. 61
21935872 2011
450
Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages. 61
21035526 2011
451
NTP 3-month toxicity studies of estragole (CAS No. 140-67-0) administered by gavage to F344/N rats and B6C3F1 mice. 61
21445103 2011
452
NTP technical report on the toxicology and carcinogenesis studies of beta-myrcene (CAS No. 123-35-3) in F344/N rats and B6C3F1 mice (Gavage studies). 61
21415873 2010
453
Contrast enhanced ultrasound in focal liver lesions--a cost efficiency study. 61
21210012 2010
454
Thoracic empyema after laparoscopic cholecystectomy: an unusual cause. 61
21170636 2010
455
[Interest of immunohistochemistry for the diagnosis of benign hepatocellular tumors]. 61
21167430 2010
456
Focal nodular hyperplasia with major sinusoidal dilatation: a misleading entity. 61
22798311 2010
457
Toxicology and carcinogenesis studies of 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (CAS No. 31508-00-6) in female harlan Sprague-Dawley rats (gavage studies). 61
21383778 2010
458
Conservative and operative management of benign solid hepatic tumours: a successful stratified algorithm. 61
20683192 2010
459
Frequent and distinct aberrations of DNA methylation patterns in fibrolamellar carcinoma of the liver. 61
21060828 2010
460
Toxicogenomic analysis of exposure to TCDD, PCB126 and PCB153: identification of genomic biomarkers of exposure to AhR ligands. 61
20959002 2010
461
Toxicology and carcinogenesis studies of isoeugenol (CAS No. 97-54-1) in F344/N rats and B6C3F1 mice (gavage studies). 61
21372857 2010
462
Expression of CYP1C1 and CYP1A in Fundulus heteroclitus during PAH-induced carcinogenesis. 61
20621368 2010
463
Toxicology and carcinogenesis studies of androstenedione (CAS No. 63-05-8) in F344/N rats and B6C3F1 mice (gavage studies). 61
21037592 2010
464
Toxicology and carcinogenesis studies of goldenseal root powder (Hydrastis Canadensis) in F344/N rats and B6C3F1 mice (feed studies). 61
21372858 2010
465
An update on indications for treatment of solid hepatic neoplasms in noncirrhotic liver. 61
20799871 2010
466
Spontaneous hepatic rupture: 13-year experience of a single center. 61
20555270 2010
467
Molecular characterization of the vascular features of focal nodular hyperplasia and hepatocellular adenoma: a role for angiopoietin-1. 61
20683953 2010
468
Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. 61
20393147 2010
469
NTP toxicology and carcinogenesis studies of 5-(Hydroxymethyl)-2-furfural (CAS No. 67-47-0) in F344/N rats and B6C3F1 mice (gavage studies). 61
20725154 2010
470
Adenoma or atypical hepatic focal nodular hyperplasia: role of preoperative imaging and laparoscopic treatment. 61
20551788 2010
471
From the archives of the AFIP: Pediatric liver masses: radiologic-pathologic correlation part 1. Benign tumors. 61
20462995 2010
472
Positive PET-CT scan in hepatocellular adenoma with concomitant benign liver tumors. 61
20227207 2010
473
[Malignant transformation of hepatocellular adenoma in men]. 61
20189337 2010
474
Hepatocellular adenoma: a case report. 61
20420118 2010
475
A Hepatocellular Adenoma in a Diet-induced Obese Mouse. 61
22319226 2010
476
Lipid droplet-associated PAT-proteins show frequent and differential expression in neoplastic steatogenesis. 61
20081801 2010
477
Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis. 54
20041408 2010
478
Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma. 61
20175035 2010
479
A hepatocellular neoplasm accompanied with massive histiocyte infiltration. 61
26189906 2010
480
Diagnosis and treatment of hepatocellular adenoma in the Netherlands: similarities and differences. 61
20357453 2010
481
Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma. 61
20357451 2010
482
Gene expression analyses of hepatocellular adenoma and hepatocellular carcinoma from the marine flatfish Limanda limanda. 61
20225674 2010
483
The hypointense liver lesion on T2-weighted MR images and what it means. 61
19901085 2010
484
Subtype classification of hepatocellular adenoma. 61
20357450 2010
485
Management of ruptured hepatocellular adenoma. 61
20357452 2010
486
Hepatic resection for inflammatory hepatocellular adenomas: pathological identification of micronodules expressing inflammatory proteins. 61
19845852 2010
487
Hepatocellular adenoma: Should phenotypic classification direct management? 61
19946304 2009
488
Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease. 61
19762333 2009
489
Proteomic analysis of liver tissue from HBx-transgenic mice at early stages of hepatocarcinogenesis. 61
19813210 2009
490
A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. 61
19664629 2009
491
Contrast-enhanced ultrasound in the detection and characterization of liver tumors. 61
19933022 2009
492
Hormonal contraceptive use among women with liver tumors: a systematic review. 61
19751862 2009
493
[Incidental ultrasound finding of a 3 cm liver nodule in a 45-year-old woman taking hormonal substitution after hysterectomy performed for cervix carcinoma]. 61
19766417 2009
494
C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. 61
19893396 2009
495
Clonality and allelotype analyses of focal nodular hyperplasia compared with hepatocellular adenoma and carcinoma. 61
19787833 2009
496
Hepatocellular adenoma: cost-effectiveness of different treatment strategies. 61
19717753 2009
497
Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. 61
19585623 2009
498
Hepatocellular adenoma in advanced-stage fatty liver disease. 61
19404203 2009
499
Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry. 61
19465902 2009
500
A case of hepatocellular carcinoma within hepatocellular adenoma in a non-cirrhotic male. 61
19543495 2009
501
Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization. 61
19669369 2009
502
Effect of chronic phenobarbitone administration on liver tumour formation in the C57BL/10J mouse. 61
19298838 2009
503
Multiple spontaneous liver cell adenomas of different types (liver adenomatosis). 61
19395881 2009
504
[Laparoscopic hepatectomy in benign solid tumor: case report]. 61
19671275 2009
505
Ectonucleoside triphosphate diphosphohydrolase type 5 (Entpd5)-deficient mice develop progressive hepatopathy, hepatocellular tumors, and spermatogenic arrest. 61
19176496 2009
506
[Surgical treatment of benign liver tumours--indications and results]. 61
19382044 2009
507
Liver transplantation for spontaneous intrapartum rupture of a hepatic adenoma. 61
19155937 2009
508
Regulation of iron metabolism-related genes in diethylnitrosamine-induced mouse liver tumors. 61
19061943 2009
509
Use of X-chromosome inactivation pattern and laser microdissection to determine the clonal origin of focal nodular hyperplasia of the liver. 61
19404847 2009
510
Erythropoietin production by a hepatic adenoma in a patient with severe erythrocytosis. 61
19339771 2009
511
Surgical management of spontaneous ruptured hepatocellular adenoma. 61
19690662 2009
512
Hepatocellular adenoma in a male with familial adenomatous polyposis coli. 61
19288049 2009
513
Behavior of hepatocellular adenoma on real-time low-mechanical index contrast-enhanced ultrasonography with a second-generation contrast agent. 61
19022997 2008
514
HB-EGF is a paracrine growth stimulator for early tumor prestages in inflammation-associated hepatocarcinogenesis. 61
18929421 2008
515
Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial). 61
19241506 2008
516
Surgical management of hepatocellular adenoma: take it or leave it? 61
18696154 2008
517
Activation of Akt-mTOR-p70S6K pathway in angiogenesis in hepatocellular carcinoma. 61
18813808 2008
518
Hepatocellular adenoma: what is new in 2008. 61
19669260 2008
519
Liver is a target of arsenic carcinogenesis. 61
18566022 2008
520
Assessing chronic liver toxicity based on relative gene expression data. 61
18585395 2008
521
Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. 54
18688875 2008
522
Percutaneous radiofrequency ablation of hepatocellular adenoma: initial experience in 10 patients. 61
17944897 2008
523
Toxicology and carcinogenesis studies of formamide (Cas No. 75-12-7) in F344/N rats and B6C3F1 mice (gavage studies). 61
18716632 2008
524
Intrahepatic extramedullary hematopoiesis mimicking a hypervascular hepatic neoplasm on dynamic- and SPIO-enhanced MRI. 61
18607123 2008
525
Induction of thyroid and liver tumors by chronic exposure to 2-methylimidazole in F344/N rats and B6C3F1 mice. 61
17924096 2008
526
Primary hepatocellular lesions: imaging findings on state-of-the-art magnetic resonance imaging, with pathologic correlation. 61
18436110 2008
527
Gene expression profiling in hepatocellular carcinoma: upregulation of genes in amplified chromosome regions. 61
18277965 2008
528
Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma. 61
18577240 2008
529
Human and mouse hepatocellular adenoma and carcinoma display similar tumorigenesis pathway alterations. 61
18314218 2008
530
Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease. 61
18083610 2008
531
Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia. 61
18191274 2008
532
Different mechanisms of DEHP-induced hepatocellular adenoma tumorigenesis in wild-type and Ppar alpha-null mice. 61
18403868 2008
533
Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. 61
17997499 2008
534
Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma. 61
18365549 2007
535
Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo. 61
18056438 2007
536
Toxicology and carcinogenesis studies of alpha-methylstyrene (Cas No. 98-83-9) in F344/N rats and B6C3F1 mice (inhalation studies). 61
18685715 2007
537
Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. 61
17637480 2007
538
Life-saving therapy for haemorrhaging liver adenomas using selective arterial embolization. 61
17696216 2007
539
[Diagnostic radiology of liver tumors. Part 1: General disease aspects and radiological procedures]. 61
17786401 2007
540
Diagnosis and management of hepatic focal nodular hyperplasia. 61
23396642 2007
541
Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. 61
17663417 2007
542
Resection of giant liver adenoma in a 17-year-old adolescent boy using venovenous bypass, total hepatic vascular isolation, and in situ cooling. 61
17706483 2007
543
Giant hepatocellular adenoma as cause of severe abdominal pain: a case report. 61
17662116 2007
544
Associated benign liver tumors in idiopathic granulomatous hepatitis: A case report. 61
17540000 2007
545
[Diagnosis and treatment of hepatocellular adenoma in the Netherlands: national agreement is desired]. 61
17665621 2007
546
[Diagnosis and treatment of hepatocellular adenoma in the Netherlands: similarities and differences]. 61
17665627 2007
547
[Hepatocellular adenoma, a tumour particularly seen in mostly young women]. 61
17665620 2007
548
Hypervascular hepatic focal lesions: spectrum of imaging features. 61
17484954 2007
549
Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. 61
17183066 2007
550
Carcinogenesis studies of benzophenone in rats and mice. 61
17187913 2007
551
Toxicology and carcinogenesis studies of dibromoacetic acid (Cas No. 631-64-1) in F344/N rats and B6C3F1 mice (drinking water studies). 61
17554398 2007
552
[Case 1: Hepatocellular adenoma and Case 2: Inflammatory/telangiectasic adenoma]. 61
17909463 2007
553
Management of a giant ruptured hepatocellular adenoma. Report of a case. 61
19582184 2007
554
Hepatocellular adenoma in a Eurasian otter (Lutra lutra). 61
17322782 2007
555
Hepatocellular adenoma with malignant alteration. 61
17523280 2007
556
Neoplasms of the liver. 61
17486052 2007
557
Toxicity and carcinogenicity of the water disinfection byproduct, dibromoacetic acid, in rats and mice. 61
17157429 2007
558
Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. 61
17283114 2007
559
Toxicology and carcinogenesis studies of methyl isobutyl ketone (Cas No. 108-10-1) in F344/N rats and B6C3F1 mice (inhalation studies). 61
17557116 2007
560
The multidisciplinary management of gastrointestinal cancer. The diagnostic and therapeutic approach for primary solid liver tumours in adults. 61
18070699 2007
561
Case-orientated approach to the management of hepatocellular adenoma. 61
17051603 2006
562
Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies). 61
17342196 2006
563
Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. 54
16949914 2006
564
Carcinogenicity and chronic toxicity in rats and mice exposed by inhalation to 1,2-dichloroethane for two years. 61
17179635 2006
565
Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization. 61
16979954 2006
566
Fat in the liver: diagnosis and characterization. 61
16477402 2006
567
Necrosis of a large hepatic tumor after hemorrhage and subsequent selective arterial embolization. 61
17009410 2006
568
Hepatocellular adenoma: findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis. 61
16708218 2006
569
Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies). 61
17342195 2006
570
Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies). 61
17160103 2006
571
Giant hepatocellular adenoma presenting with chronic iron deficiency anemia. 61
16817847 2006
572
Reevaluation of a twenty-four-month chronic toxicity/carcinogenicity study of hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) in the B6C3F1 hybrid mouse. 61
16940009 2006
573
Carcinogenicity of malachite green chloride and leucomalachite green in B6C3F1 mice and F344 rats. 61
16554117 2006
574
Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (gavage studies). 61
17160104 2006
575
Giant hepatic adenoma with bone marrow metaplasia not associated with oral contraceptive intake. 61
16934137 2006
576
APC and CTNNB1 mutations are rare in sporadic ependymomas. 54
16843107 2006
577
[Hepatocellular adenoma. Malignancy potential and differentiation from hepatocellular carcinoma]. 61
16736176 2006
578
Metastasizing oral squamous cell carcinoma in an aged pig. 61
16847003 2006
579
[Nodular lesions of liver parenchyma caused by pathological vascularisation/perfusion]. 61
16773311 2006
580
[Three-dimensional reconstruction and image fusion between liver focal lesions and dynamic contrast-enhanced magnetic resonance angiography]. 61
16831284 2006
581
A biological effects monitoring survey of Cardigan Bay using flatfish histopathology, cellular biomarkers and sediment bioassays: findings of the Prince Madog Prize 2003. 61
16730791 2006
582
Genetics of hepatocellular tumors. 54
16799619 2006
583
[Polycystic ovary syndrome and hepatocellular adenoma related to long-term use of sodium valproate in a young woman]. 61
16715935 2006
584
NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies). 61
16835634 2006
585
A long-term investigation of the anti-hepatocarcinogenic potential of an indigenous medicine comprised of Nigella sativa, Hemidesmus indicus and Smilax glabra. 61
16684351 2006
586
NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies). 61
16835633 2006
587
Differential diagnosis of focal nodular hyperplasia with quantitative parametric analysis in contrast-enhanced sonography. 61
16481921 2006
588
Diagnostic accuracy of contrast-enhanced ultrasound in focal lesions of the liver using cadence contrast pulse sequencing. 61
16470478 2006
589
Toxicology and carcinogenesis studies of benzophenone (CAS No. 119-61-9) in F344/N rats and B6C3F1 mice (feed studies). 61
16741556 2006
590
NTP Toxicology and carcinogenesis studies of bromodichloromethane (CAS No. 75-27-4) in male F344/N rats and female B6C3F1 mice (Drinking Water Studies). 61
16741555 2006
591
NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies). 61
16628245 2006
592
Magnetic resonance-guided focused ultrasound surgery (MRgFUS). Four ablation treatments of a single canine hepatocellular adenoma. 61
18333139 2006
593
Identification of a unique gene expression signature that differentiates hepatocellular adenoma from well-differentiated hepatocellular carcinoma. 61
16327432 2005
594
The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. 54
15920546 2005
595
Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver. 61
16161006 2005
596
Dose-dependence of promotion of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-induced rat hepatocarcinogenesis by ethanol: evidence for a threshold. 61
16271068 2005
597
NTP carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol, nitromethane, and 1,2,3-trichloropropane (cas nos. 3296-90-0, 75-52-5, and 96-18-4) in guppies (Poecilia reticulata) and medaka (Oryzias latipes) (Waterborne Studies). 61
16362062 2005
598
Management of hepatocellular adenoma: solitary-uncomplicated, multiple and ruptured tumors. 61
16237767 2005
599
[Out of phase magnetic resonance imaging and liver applications]. 61
16224338 2005
600
Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. 61
16046421 2005
601
Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility. 61
15728704 2005
602
Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. 61
15887105 2005
603
Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas. 61
15649945 2005
604
Hepatocellular adenoma: imaging findings and pathological correlation. 61
15888286 2005
605
Successful treatment of hepatocellular adenoma with percutaneous radiofrequency ablation. 61
15728604 2005
606
[Mutation analysis of glycogen debrancher enzyme gene in five Chinese patients with glycogen storage disease type III]. 61
15833157 2005
607
[The place of MRI in the hepatic tumors]. 61
15969233 2005
608
Classification of proliferative hepatocellular lesions in harlan sprague-dawley rats chronically exposed to dioxin-like compounds. 61
15805068 2005
609
Large liver cell dysplasia in hepatitis B virus x transgenic mouse liver and human chronic hepatitis B virus-infected liver. 61
15785085 2005
610
Surgical treatment of benign liver tumors. 61
16541615 2005
611
Dose-additive carcinogenicity of a defined mixture of "dioxin-like compounds". 61
15626646 2005
612
Effect of ethanol on the tumorigenicity of urethane (ethyl carbamate) in B6C3F1 mice. 61
15582191 2005
613
[Hepatic tumors in childhood: experience on 245 tumors and review of literature]. 61
15785401 2004
614
alpha(2)-Macroglobulin: a novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers. 61
15509519 2004
615
Liver carcinogenesis and formation of 8-hydroxy-deoxyguanosine in C3H/HeN mice by oxidized dietary oils containing carcinogenic dicarbonyl compounds. 61
15350677 2004
616
Carcinogenicity and chronic toxicity after inhalation exposure of rats and mice to N,N-dimethylformamide. 61
15613765 2004
617
Images in hepatology. Telangiectatic adenoma: a variant of hepatocellular adenoma. 61
15657559 2004
618
[The relationship between benign liver tumors and free radicals]. 61
15559531 2004
619
NTP technical report on the toxicology and carcinogenesis studies of Stoddard Solvent IIC (Cas No. 64742-88-7) in F344/N rats and B6C3F1 mice (inhalation studies). 61
15625557 2004
620
Mutation of TCF1 encoding hepatocyte nuclear factor 1alpha in gynecological cancer. 54
15326484 2004
621
Kupffer cell function of hepatocellular adenoma: pulse sequence effects in superparamagnetic iron oxide-enhanced magnetic resonance imaging. 61
15242510 2004
622
trans-activation of PPARalpha and induction of PPARalpha target genes by perfluorooctane-based chemicals. 61
15071170 2004
623
Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers. 61
15269691 2004
624
Characterisation of focal liver lesions with contrast enhanced ultrasonography. 61
15234021 2004
625
Inhalation toxicology and carcinogenesis studies of propylene glycol mono-t-butyl ether in rats and mice. 61
15125995 2004
626
Focal nodular hyperplasia of the liver: pathological analysis of 11 cases. 61
15138109 2004
627
Hepatocellular adenoma and focal nodular hyperplasia after long-term use of danazol for endometriosis: a case report. 61
15221322 2004
628
Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. 61
15131793 2004
629
NTP toxicology and carcinogenesis studies of triethanolamine (Cas No. 102-71-6) in B6C3F1 mice (dermal studies). 61
15213765 2004
630
NTP technical report on the toxicology and carcinogenesis studies of Elmiron (Cas No. 37319-17-8) in F344/N rats and B6C3F1 mice (Gavage Studies). 61
15213766 2004
631
Hepatocellular adenoma in a 12-year-old crossbred German shepherd dog. 61
15144108 2004
632
Multiple chromosomal abnormalities in human liver (pre)neoplasia. 61
15030983 2004
633
Fibrolamellar hepatocellular carcinoma occurring 5 years after hepatocellular adenoma in a 14-year-old girl: a case report with comparative genomic hybridization analysis. 61
14736278 2004
634
Hepatocellular adenomatosis is a rare entity that may mimic other hepatocellular lesions. 61
15129911 2004
635
Expression of fibrillin-1 in focal nodular hyperplasia of the liver: a role in microcirculation adaptability. 61
14960209 2004
636
Nodular lesions associated with abnormal liver circulation. 61
15383736 2004
637
Hepatic adenomas in male patients. 61
18333041 2004
638
Angiotensin I-converting enzyme (CD143) is down-regulated in focal nodular hyperplasia of the liver. 61
14707868 2004
639
Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. 61
14730031 2004
640
Treatment of unresectable hepatocellular adenoma in dogs with transarterial iodized oil and chemotherapy with and without an embolic agent: a report of two cases. 61
19379180 2003
641
Factors contributory to early death of young CD-1 mice in carcinogenicity studies. 61
12962977 2003
642
Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. 54
14598263 2003
643
Toxicity and carcinogenicity of riddelliine in rats and mice. 61
12927348 2003
644
Induction of apoptosis in mouse liver adenoma and carcinoma in vivo by transforming growth factor-beta1. 61
12905009 2003
645
Preventive effect of fermented brown rice and rice bran on diethylnitrosoamine and phenobarbital-induced hepatocarcinogenesis in male F344 rats. 61
12792738 2003
646
Spontaneous development of hepatocellular carcinomas in the FLS mice with hereditary fatty liver. 61
12860288 2003
647
Toxicology and carcinogenesis studies of riddelliine (CAS No. 23246-96-0) in F344/N rats and B6C3F1 mice (gavage studies). 61
12844193 2003
648
Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fisher 344 male rats [Mechanisms of Ageing and Development 123 (2002) 1665-1680]. 61
12825548 2003
649
A 20-year follow-up of a male patient with type Ia glycogen storage disease. 61
12846528 2003
650
[Pigmented hepatocellular adenoma of the liver caused by long-term use of phenobarbital]. 61
12795231 2003
651
Concomitant hepatocellular adenoma and adenomatous hyperplasia in a patient without cirrhosis. 61
12632534 2003
652
Expression of hepatitis C virus core protein associated with malignant lymphoma in transgenic mice. 61
12493492 2003
653
Carcinogenesis of the food mutagen PhIP in mice is independent of CYP1A2. 61
12663521 2003
654
Histopathological biomarkers in estuarine fish species for the assessment of biological effects of contaminants. 61
12502035 2003
655
Benign hepatic tumours. 61
12650132 2003
656
Hepatocellular adenoma and polycystic ovary syndrome. 61
12640725 2003
657
Liver adenomatosis. 61
12617455 2003
658
Hepatocellular adenoma presenting as a giant multicystic tumor of the liver. 61
12768399 2003
659
Chemopreventive effects of melatonin on diethylnitrosamine and phenobarbital-induced hepatocarcinogenesis in male F344 rats. 61
15087267 2003
660
CD 34 expression in chronic and neoplastic liver diseases. 61
12434120 2002
661
Toxicology and carcinogenesis study of chloral hydrate (ad libitum and dietary controlled) (CAS no. 302-17-0) in male B6C3F1 mice (gavage study). 61
12533745 2002
662
Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation. 61
12460917 2002
663
Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fischer 344 male rats. 61
12470904 2002
664
[Liver transection with the harmonic scalpel in elective liver surgery]. 61
12666483 2002
665
Solid adenoma with exclusive hepatocellular differentiation: a new variant among pancreatic benign neoplasms? 61
12447684 2002
666
P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. 61
12297840 2002
667
Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. 61
12235331 2002
668
Two case reports of childhood liver cell adenomas harboring beta-catenin abnormalities. 54
12203220 2002
669
Hepatocellular adenoma: diagnostic difficulties and novel imaging techniques. 61
12153946 2002
670
Intrahepatic huge hematoma due to rupture of small hepatocellular adenoma: a case report. 61
12048069 2002
671
Cytokeratin 5/6 immunostaining in hepatobiliary and pancreatic neoplasms. 61
12051633 2002
672
Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema. 61
11983460 2002
673
Toxicology and carcinogenesis studies of o-nitrotoluene sulfone (CAS no. 88-72-2) in F344/N rats and B6C3F(1) mice (feed studies). 61
12087420 2002
674
Hepatic neoplasms: computed tomography and magnetic resonance features. 61
11907365 2002
675
Idiopathic hepatocellular adenoma with intratumoral haemorrhage. 61
11943966 2002
676
[When is resection indicated in primary liver tumors?]. 61
12030052 2002
677
[Spontaneous rupture of hepatic focal nodular hyperplasia--a rare cause of acute intraabdominal bleedingf]. 61
12085286 2002
678
[Hepatocellular carcinoma arising in hepatocellular adenoma]. 61
12499824 2002
679
[Clinicopathological observaton on nodular regenerative hyperplasia of the liver]. 61
11955333 2002
680
Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors. 54
11896580 2002
681
Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. 61
11832450 2002
682
Carcinogenic effect of combined administration of 2,4-diaminoanisole sulfate, 4,4'-thiodianiline and N,N'-diethylthiourea in male Wistar rats. 61
12382023 2002
683
Comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH) in the diagnosis of hepatocellular carcinoma. 61
12353141 2002
684
A liver tumour as an incidental finding: differential diagnosis and treatment. 61
12408510 2002
685
Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies). 61
11852482 2001
686
Benign nodular hepatocellular lesions caused by abnormal hepatic circulation: etiological analysis and introduction of a new concept. 61
11851827 2001
687
[Focal nodular hyperplasia of the liver]. 61
11730595 2001
688
Hepatic progenitor cells in hepatocellular adenomas. 61
11684955 2001
689
[Highly differentiated hepatocellular tumors. Concepts, criteria, and differential diagnosis]. 61
11766640 2001
690
Chronic toxicity and oncogenicity of N-methylpyrrolidone (NMP) in rats and mice by dietary administration. 61
11665646 2001
691
Pathology of aging B6;129 mice. 61
11794381 2001
692
[Hepatocellular adenoma confirmed by Doppler ultrasonography and laparoscopy]. 61
11760655 2001
693
[Benign hepatic tumors: diagnostic management and therapeutic outcome]. 61
11894690 2001
694
Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. 61
11529826 2001
695
Successful outcome after transplantation of a donor liver with focal nodular hyperplasia. 61
11460236 2001
696
Hepatic adenomas: imaging and pathologic findings. 61
11452062 2001
697
Di(2-ethylhexyl)phthalate induces hepatocellular adenoma in transgenic mice carrying a human prototype c-Ha-ras gene in a 26-week carcinogenicity study. 61
11560251 2001
698
Focal nodular hyperplasia and hepatocellular adenoma of the liver: differentiation with multiphasic helical CT. 61
11373219 2001
699
Exophytic benign tumors of the liver: appearance on MRI. 61
11672619 2001
700
Chemopreventive effects of scordinin on diethylnitrosamine and phenobarbital-induced hepatocarcinogenesis in male F344 rats. 61
11429047 2001
701
Hepatic toxicity and recovery of Fischer 344 rats following exposure to 2-aminoanthracene by intraperitoneal injection. 61
11442019 2001
702
Diagnostic impact of fluorescence in situ hybridization in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma. 61
11333302 2001
703
Hepatic adenomatosis: gadolinium-enhanced dynamic MR findings. 61
11429950 2001
704
Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular carcinoma. 61
11301474 2001
705
Treatment of ruptured hepatocellular adenoma. 61
11167868 2001
706
[Liver resection and liver transplantation in liver cell adenoma, hepatocellular carcinoma and fibrolamellar liver carcinoma]. 61
11206098 2001
707
Hepatocellular adenoma in type Ia glycogen storage disease. 61
11211215 2001
708
Toxicology and carcinogenesis studies of coconut oil acid diethanolamine condensate (CAS No. 68603-42-9) in F344/N rats and B6C3F1 mice (dermal studies). 61
12571684 2001
709
Liver tumors in children and young patients: sonographic and color Doppler findings. 61
11029091 2000
710
Cholangioscopic findings in bile duct tumors. 61
11060187 2000
711
Neoplasia in zebrafish (Danio rerio) treated with N-methyl-N'-nitro-N-nitrosoguanidine by three exposure routes at different developmental stages. 61
11026608 2000
712
Hepatocellular adenoma and focal nodular hyperplasia: a series of 24 patients with clinicopathological and radiological correlation. 61
11776086 2000
713
Hepatocellular adenoma of the placenta: report of a case associated with maternal bicornuate uterus and fetal renal dysplasia. 61
10971709 2000
714
Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia. 61
11100357 2000
715
NTP Toxicology and Carcinogenesis Studies of Primidone (CAS No. 125-33-7) in F344/N Rats and B6C3F1 Mice (Feed Studies). 61
12571687 2000
716
NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies). 61
12563349 2000
717
Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging. 61
10882267 2000
718
Comparison of the DNA content in liver cell adenoma, hepatocellular carcinoma and regenerative nodules. 61
10928119 2000
719
Hepatocellular alterations after intraportal transplantation of ovarian tissue in ovariectomized rats. 61
10793073 2000
720
[Liver resection using the harmonic scalpel]. 61
10916447 2000
721
Hepatocarcinogenesis in female Sprague-Dawley rats following discontinuous treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin. 61
10774815 2000
722
Management of hepatocellular adenoma during pregnancy. 61
10847490 2000
723
Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. 61
10715059 2000
724
Utility of CD34 reactivity in evaluating focal nodular hepatocellular lesions sampled by fine needle aspiration biopsy. 61
10740609 2000
725
No consistent pattern of mutations in p53 and ras genes in liver tumors of rat treated with the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX). 61
11152562 2000
726
Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. 61
10632334 1999
727
NTP Toxicology and Carcinogenesis Studies of Triethanolamine (CAS No. 102-71-6) in F344 Rats and B6C3F1 Mice (Dermal Studies). 61
12594526 1999
728
CYP1A2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in mice. 61
10469630 1999
729
Spontaneous hepatocellular adenoma with marked cystic degeneration. 61
10576380 1999
730
NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies). 61
12571678 1999
731
NTP Toxicology and Carcinogenesis Studies of Lauric Acid Diethanolamine Condensate (CAS NO. 120-40-1) in F344/N Rats and B6C3F1 Mice (Dermal Studies). 61
12571683 1999
732
NTP Toxicology and Carcinogenesis Studies of Diethanolamine (CAS No. 111-42-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies). 61
12571685 1999
733
[Hepatocellular adenoma. Case report]. 61
10500431 1999
734
Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation. 61
10194790 1999
735
The human p53 gene mutated at position 249 per se is not sufficient to immortalize human liver cells. 61
10051487 1999
736
[Protection against synergistic hepatocarcinogenesis of hepatitis B virus expression and aflatoxin B1 by antioxidant 2(3)-tert-4 -hydroxyanisole (BHA) in HBV large envelope transgenic mice]. 61
11864462 1999
737
Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging. 61
10087113 1999
738
NTP Toxicology and Carcinogenesis Studies of Ethylbenzene (CAS No. 100-41-4) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). 61
12579207 1999
739
A 42-year-old woman with liver masses and long-term use of oral contraceptives. 61
10518313 1999
740
Management of focal nodular hyperplasia and hepatocellular adenoma. 61
10414183 1999
741
Modern oral contraceptive use and benign liver tumors: the German Benign Liver Tumor Case-Control Study. 61
10036602 1998
742
[Treatment of 8 patients with an acute hemorrhage in a hepatocellular adenoma at the Academic Medical Center, Amsterdam]. 61
10028327 1998
743
[Hepatocellular adenoma in 20 patients; recommendations for treatment]. 61
10028326 1998
744
Hepatocyte growth factor in transgenic mice. 61
10193310 1998
745
MRI in focal liver disease: a comparison of small and ultra-small superparamagnetic iron oxide as hepatic contrast agents. 61
9786144 1998
746
Spontaneous neoplasms in control Wistar rats: a comparison of reviews. 61
9848105 1998
747
NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies). 61
12571677 1998
748
Hemoperitoneum due to (hepatocellular) adenoma. 61
10505574 1998
749
Hepatic (hepatocellular) adenoma of the placenta: a study of four cases. 61
9656120 1998
750
Point mutations of the c-H-ras gene in spontaneous liver tumors of transgenic mice carrying the human c-H-ras gene. 61
9715515 1998
751
Radiology case of the month. Incidental liver mass found on abdominal CT. Hepatocellular adenoma. 61
9677782 1998
752
NTP Toxicology and Carcinogenesis Studies of Technical Grade Sodium Xylenesulfonate (CAS No. 1300-72-7) in F344/N Rats and B6C3F1 Mice (Dermal Studies). 61
12579200 1998
753
The Rocky liver: radiologic-pathologic correlation of calcified hepatic masses. 61
9599391 1998
754
The significance of colour velocity and spectral Doppler ultrasound in the differentiation of liver tumours. 61
9614278 1998
755
Benign hepatocellular tumor of the placenta. 61
9500778 1998
756
[Differential diagnosis and therapy of benign liver tumors]. 61
9545855 1998
757
Liver tumors induced in B6C3F1 mice by 7-chlorobenz[a]anthracene and 7-bromobenz[a]anthracene contain K-ras protooncogene mutations. 61
9461013 1998
758
Suppressive effect of low amounts of safflower and perilla oils on diethylnitrosamine-induced hepatocarcinogenesis in male F344 rats. 61
9631489 1998
759
[Diagnostic and therapeutic strategies in hepatocellular adenoma]. 61
9556886 1998
760
[The role of laparoscopy and laparoscopic ultrasonography in the diagnosis and differential diagnosis of nodular hepatocellular lesions]. 61
11247062 1998
761
Establishment and characterization of a nontumorigenic cell line derived from a human hepatocellular adenoma expressing hepatocyte-specific markers. 61
9367626 1997
762
Benign liver tumors: differential diagnosis and indications for surgery. 61
9361515 1997
763
Spontaneous gastric carcinoid tumors in the striped field mouse (Apodemus agrarius). 61
9300368 1997
764
Severe upper abdominal pain due to a large hepatocellular adenoma. 61
9260490 1997
765
Benign liver tumors. 61
9113675 1997
766
Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver. 54
9210259 1997
767
NTP Toxicology and Carcinogenesis Studies of D&C Yellow No. 11 (CAS No. 8003-22-3) in F344/N Rats (Feed Studies). 61
12587013 1997
768
Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643. 61
9111198 1997
769
NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies). 61
12594525 1997
770
Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. 61
9096596 1997
771
Solitary hepatocellular adenoma in infancy. 61
9269027 1997
772
Diagnostic criteria for degenerative, inflammatory, proliferative nonneoplastic and neoplastic liver lesions in medaka (Oryzias latipes): consensus of a National Toxicology Program Pathology Working Group. 61
9125779 1997
773
Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. 61
9138172 1997
774
Childhood hepatocellular adenoma in familial adenomatous polyposis: mutations in adenomatous polyposis coli gene and p53. 61
9041254 1997
775
Hepatocellular neoplasms induced by low-number pancreatic islet transplants in streptozotocin diabetic rats. 61
9060843 1997
776
NTP Toxicology and Carcinogenesis Studies of Nitromethane (CAS No. 75-52-5) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). 61
12587015 1997
777
Suppressive effects of S-methyl methanethiosulfonate on promotion stage of diethylnitrosamine-initiated and phenobarbital-promoted hepatocarcinogenesis model. 61
9045889 1997
778
[Surgical therapy of primary and secondary liver tumors]. 61
9064725 1997
779
Differentiation of hepatocellular adenoma and focal nodular hyperplasia of the liver: comparison of power Doppler imaging and conventional color Doppler sonography. 61
9369506 1997
780
[Focal nodular hyperplasia and hepatocellular adenoma in women. Current data]. 61
9587556 1997
781
NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies). 61
12579199 1996
782
Skin and liver diseases induced in flounder (Platichthys flesus) after long-term exposure to contaminated sediments in large-scale mesocosms. 61
8959412 1996
783
NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies). 61
12594529 1996
784
[Primary nontrophoblastic tumors of the placenta]. 61
9289433 1996
785
NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). 61
12692653 1996
786
Large encapsulated hepatocellular adenoma in a male. 61
8877992 1996
787
NTP Toxicology and Carcinogenesis Studies of Acetonitrile (CAS No. 75-05-8) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). 61
12594528 1996
788
Toxicity and carcinogenicity of delta 9-tetrahydrocannabinol in Fischer rats and B6C3F1 mice. 61
8812248 1996
789
Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist. 61
8655665 1996
790
Hepatocellular adenoma case report with Tc-99m SC uptake and radiologic correlation. 61
8741881 1996
791
Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. 61
7489973 1995
792
Hepatocellular adenoma. 61
7484578 1995
793
[The regression of a hepatocellular adenoma after the withdrawal of hormonal contraception]. 61
8527762 1995
794
Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats. 61
7586202 1995
795
Benign myxoid hepatocellular tumor: a variant of liver cell adenoma. 61
8531591 1995
796
Hepatocellular adenoma: MR imaging features with pathologic correlation. 61
7618545 1995
797
Inhalation oncogenicity bioassay in rats and mice with vinyl fluoride. 61
7589911 1995
798
NTP Toxicology and Carcinogenesis Studies of Methylphenidate Hydrochloride (CAS No. 298-59-9) in F344/N Rats and B6C3F1 Mice (Feed Studies). 61
12595924 1995
799
Systemic AA amyloidosis induced by oral contraceptive-associated hepatocellular adenoma: a 13-year follow up. 61
7674844 1995
800
NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice. 61
12616302 1995
801
Liver transplantation for treatment of giant hepatocellular adenomas. 61
9346548 1995
802
Hepatocarcinogenesis in p53-deficient mice. 61
7893366 1995
803
Further evidence for promoter-dependent development of hepatoblastoma in the mouse. 61
7882299 1995
804
p53 immunoreactivity in hepatocellular adenoma, focal nodular hyperplasia, cirrhosis and hepatocellular carcinoma. 61
7713485 1995
805
Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma. 61
7740799 1995
806
Tumor induction in mice administered neonatally with bis(2-oxopropyl)nitrosamine. 61
7732518 1994
807
NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies). 61
12595928 1994
808
Fallacies of the fine needle aspiration cytology of surgical lesions of liver. 61
7814899 1994
809
Morphology and incidence of hepatic foci of cellular alteration in Sprague-Dawley rats. 61
7899781 1994
810
[Liver resection from the viewpoint of the internist]. 61
8069890 1994
811
Primary liver neoplasms: MR imaging with pathologic correlation. 61
8066263 1994
812
Light and electron microscopic analysis of liver sinusoids during hepatocarcinogenesis with 2-acetylaminofluorene in rats. 61
8014107 1994
813
Partial characterization of a cDNA for human stearoyl-CoA desaturase and changes in its mRNA expression in some normal and malignant tissues. 61
7909540 1994
814
Glycogen storage disease associated with Niemann-Pick disease: histochemical, enzymatic, and lipid analyses. 61
8058718 1994
815
RT-PCR detection of fibronectin EDA+ and EDB+ mRNA isoforms: molecular markers for hepatocellular carcinoma. 61
7509777 1994
816
Hepatocellular adenoma: color Doppler US and pathologic correlations. 61
8115621 1994
817
Hepatocellular adenoma in a beta-thalassemic woman having secondary iron overload. 61
7798835 1994
818
NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies). 61
12616301 1994
819
NTP Toxicology and Carcinogenesis Studies of Barium Chloride Dihydrate (CAS No. 10326-27-9) in F344/N Rats and B6C3F1 Mice (Drinking Water Studies). 61
12616299 1994
820
Hepatocellular adenoma in glycogen storage disease type IV. 61
8285839 1994
821
[Hepatocellular adenoma in a woman following administration of danazol]. 61
7875404 1994
822
NTP Toxicology and Carcinogenesis Studies of Triamterene (CAS No. 396-01-0) in F344/N Rats and B6C3F1 Mice (Feed Studies). 61
12616291 1993
823
NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). 61
12616289 1993
824
NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). 61
12616288 1993
825
Hepatocellular adenoma with areas of bone marrow: report of a case. 61
8394656 1993
826
NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies). 61
12595920 1993
827
NTP Toxicology and Carcinogenesis Studies of Polybrominated Biphenyls (CAS No. 67774-32-7)(Firemaster FF-1(R)) in F344/N Rats and B6C3F1 Mice (Feed Studies). 61
12637961 1993
828
NTP Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies). 61
12616304 1993
829
NTP Toxicology and Carcinogenesis of 1,2,3-Trichloropropane (CAS No. 96-18-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies). 61
12692652 1993
830
Analysis of intestinal flora of a patient with congenital absence of the portal vein. 61
8364525 1993
831
Lack of demonstrable chromosome allele loss in hepatocellular adenoma. 61
21573655 1993
832
NTP Toxicology and Carcinogenesis Studies of 1,3-Butadiene (CAS No. 106-99-0) in B6C3F1 Mice (Inhalation Studies). 61
12616297 1993
833
NTP Toxicology and Carcinogenesis Studies of p-Nitroaniline (CAS No. 100-01-6) in B6C3F1 Mice (Gavage Studies). 61
12616293 1993
834
NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies). 61
12616295 1993
835
Glycogen storage disease I and hepatocellular tumours. 61
8391447 1993
836
[Hepatocellular adenoma after oral contraception]. 61
1329298 1992
837
[Treatment of benign tumors of the liver]. 61
1333631 1992
838
Morphological differences between hepatocellular carcinoma and hepatocellular carcinomalike lesions. 61
1319947 1992
839
[Static and dynamic scintigraphy of the liver using labeled erythrocytes in the diagnosis of hepatic hemangioma]. 61
1336856 1992
840
Immunoreactivity for c-erbB-2 oncopeptide in benign and malignant diseases of the liver. 61
1374219 1992
841
Resection of a large liver cell adenoma originating in the caudate lobe. 61
1321785 1992
842
NTP Toxicology and Carcinogenesis Studies of Ethylene Thiourea (CAS: 96-45-7) in F344 Rats and B6C3F1 Mice (Feed Studies). 61
12637971 1992
843
Toxicology and Carcinogenesis Studies of g-Butyrolactone (CAS No. 96-48-0) in F344/N Rats and B6C3F1 Mice (Gavage Studies). 61
12621512 1992
844
[The imaging diagnosis of hepatic focal nodular hyperplasia]. 61
1664964 1991
845
Induction of renal cell tumors in rats and mice, and enhancement of hepatocellular tumor development in mice after long-term hydroquinone treatment. 61
1752780 1991
846
The risk of liver neoplasia in relation to combined oral contraceptive use. 61
1651205 1991
847
Neoplasms and nonneoplastic liver lesions in winter flounder, Pseudopleuronectes americanus, from Boston Harbor, Massachusetts. 61
1646709 1991
848
Connective tissue content of fibrolamellar carcinoma and other human liver tumors. 61
1668900 1991
849
Connective tissue content of fibrolamellar carcinoma and other human liver tumors. 61
1668901 1991
850
Diethylnitrosamine-induced metastasizing hepatocellular carcinomas in New Zealand white rabbits. A tumor model for clinical investigations. 61
2007610 1991
851
[Liver tumors caused by androgenic steroids]. 61
2234943 1990
852
No evidence of toxicity or carcinogenicity of pentaerythritol tetranitrate given in the diet to F344 rats and B6C3F1 mice for up to two years. 61
2254587 1990
853
Hepatic neoplasms in the mummichog Fundulus heteroclitus from a creosote-contaminated site. 61
2168287 1990
854
Combination oral contraceptives and cancer risk. 61
2202849 1990
855
Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver. 61
1971196 1990
856
Danazol-induced hepatocellular adenoma. 61
2159700 1990
857
Systemic AA amyloidosis induced by liver cell adenoma. 61
2157638 1990
858
Dose-response relationships in promotion of rat hepatocarcinogenesis by 17 alpha-ethinylestradiol. 61
1968981 1990
859
[Pathobiology of human primary benign and malignant liver tumors]. 61
2407943 1990
860
Danazol and hepatic neoplasia: a case report. 61
2561047 1989
861
NTP Toxicology and Carcinogenesis Studies of Chloroethane (Ethyl Chloride) (CAS No. 75-00-3) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). 61
12704438 1989
862
NTP Toxicology and Carcinogenesis Studies of Pentaerythritol Tetranitrate (CAS No. 78-11-5) with 80% D-Lactose Monohydrate (PETN, NF) in F344/N Rats and B6C3F1 Mice (Feed Studies). 61
12692639 1989
863
Association of focal nodular hyperplasia and hepatic hemangioma. 61
2542117 1989
864
Clinical significance of 99mTc-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) in the diagnosis of intrahepatic masses. 61
2546192 1989
865
Primary liver neoplasms: evaluation of proliferative index using MoAb Ki67. 61
2547043 1989
866
Primary hepatocellular adenoma in men. 61
2541173 1989
867
Benign liver tumors. 61
2544347 1989
868
[Hepatocellular adenoma and focal nodular hyperplasia]. 61
2561631 1989
869
Infrequent activation of K-ras, H-ras, and other oncogenes in hepatocellular neoplasms initiated by methyl(acetoxymethyl)nitrosamine, a methylating agent, and promoted by phenobarbital in F344 rats. 61
2645046 1989
870
Unusual histochemical pattern in preneoplastic hepatic foci characterized by hyperactivity of several enzymes. 61
2569254 1989
871
Morphometric characteristics of hepatocellular dysplasia. 61
3207457 1988
872
Fibrolamellar carcinoma of the liver: CT, ultrasound and angiography. Case report. 61
2838279 1988
873
Hepatocellular tumorigenicity of butylated hydroxytoluene administered orally to B6C3F1 mice. 61
3128505 1988
874
Benign tumors and pseudotumors of the liver. 61
3291906 1988
875
Morphometric evaluation of hepatocellular proliferative lesions in the rat liver. 61
3222623 1988
876
[Benign liver tumor during pregnancy. Review of the literature and management (apropos of a case)]. 61
2838545 1988
877
Liver adenoma and focal nodular hyperplasia in a man with high endogenous sex steroids. 61
2824277 1987
878
Tumorigenic responses to lindane in mice: potentiation by a dominant mutation. 61
2445499 1987
879
Accumulation of technetium-99m sulfur colloid by hepatocellular adenoma: scintigraphic-pathologic correlation. 61
3034012 1987
880
Nodular regenerative hyperplasia of the liver: clinical and radiologic observations. 61
3548283 1987
881
[Giant hepatocellular adenoma of the liver removed at surgery]. 61
2825626 1987
882
Twenty-one-month evaluation of misoprostol for carcinogenicity in CD-1 mice. 61
3112921 1987
883
Pathology of BHA- and BHT-induced lesions. 61
3804118 1986
884
Pathology of aging female SENCAR mice used as controls in skin two-stage carcinogenesis studies. 61
3780636 1986
885
Hepatocellular adenoma and nodular regenerative hyperplasia of the liver in a young man. 61
3020120 1986
886
Hepatocellular adenoma of the placenta. 61
3013034 1986
887
Diagnosis of primary hepatic neoplasms by fine-needle aspiration cytology. 61
3013538 1986
888
Hepatocellular adenoma related to oral contraceptive use--report of two cases. 61
3023743 1986
889
Systemic reactive amyloidosis caused by hepatocellular adenoma. A case report. 61
3722793 1986
890
National Toxicology Program nomenclature for hepatoproliferative lesions of rats. 61
3764323 1986
891
Toxicity and carcinogenicity of chlorodibromomethane in Fischer 344/N rats and B6C3F1 mice. 61
3005099 1985
892
Tumorigenesis and cystic lesion of the liver by N-bis(2-hydroxypropyl)nitrosamine in ddY mice. 61
3007772 1985
893
Oncogenic evaluation of tetrachlorvinphos in the B6C3F1 mouse. 61
4065460 1985
894
[Hepatocellular adenoma]. 61
3006208 1985
895
Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice. 61
4043598 1985
896
Chronic hepatitis and hepatocellular carcinoma associated with persistent woodchuck hepatitis virus infection. 61
2994274 1985
897
Multiple hepatic adenomas after long-term therapy with testosterone enanthate. Review of the literature. 61
2997324 1985
898
Cytological effects of sulfur and selenium purine analogues on two transplantable hepatomas and on normal renewing cells in mice. 61
6722809 1984
899
[Case of a patient with a hepatocellular adenoma of the liver]. 61
6098768 1984
900
Sequential histopathologic analysis of alpha-hexachlorocyclohexane-induced hepatic megalocytosis and adenoma formation in the HPB mouse. 61
6197553 1983
901
Carcinogenesis Studies of Eugenol (CAS No. 97-53-0) in F344/N Rats and B6C3F1 Mice (Feed Studies). 61
12778213 1983
902
[Hepatocellular adenoma within focal nodular hyperplasia]. 61
6313462 1983
903
Test and teach. Number forty-one. Diagnosis: hepatocellular adenoma of the liver in a patient on oral contraceptive therapy. 61
6316235 1983
904
NTP Carcinogenesis Studies of 4,4'-Methylenedianiline Dihydrochloride (CAS No. 13552-44-8) in F344/N Rats and B6C3F1 Mice (Drinking Water Studies). 61
12750745 1983
905
Carcinogenesis Studies of Pentachloroethane (CAS No. 76-01-7) in F344/N Rats and B6C3F1 Mice (Gavage Study). 61
12778204 1983
906
Human liver tumors in relation to steroidal usage. 61
6307679 1983
907
Agreement between women's histories of oral contraceptive use and physician records. 61
6302013 1983
908
[Focal nodular hyperplasia, hepatocellular adenoma and hormonal contraceptives]. 61
6300822 1983
909
[Hepatocellular adenoma following long-term intake of ovulation inhibitors]. 61
6306951 1983
910
[Association of hepatocellular adenoma and focal nodular hyperplasia of the liver in a woman on oral contraceptives]. 61
6295869 1982
911
A hepatocellular adenoma in a rattlesnake. 61
6292263 1982
912
Liver adenoma with granulomas. The appearance of granulomas in oral contraceptive-related hepatocellular adenoma and in the surrounding nontumorous liver. 61
6896136 1982
913
[A case of benign hepatocellular adenoma]. 61
6281713 1982
914
Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives. 61
6271517 1981
915
Hepatocellular adenoma in a young woman with beta-thalassemia and secondary iron overload. 61
6263745 1981
916
Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives. 61
6263214 1981
917
Benign hepatocellular tumors: a regional survey. 61
6261404 1981
918
Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. 61
6248194 1980
919
[Radiology disease of rare liver tumors (author's transl)]. 61
6248922 1980
920
Carcinogenicity of 4-chloro-o-phenylenediamine, 4-chloro-m-phenylenediamine, and 2-chloro-p-phenylenediamine in Fischer 344 rats and B6C3F1 mice. 61
7273282 1980
921
[Quantitative morphological investigations in livers and liver tumors after taking contraceptives (author's transl)]. 61
7445804 1980
922
Comparative study of tumorigenicity in mice administered transplacentally or neonatally with metabolites of tryptophan and its related compounds. 61
6248561 1980
923
[Angiography in benign hepatocellular tumors: focal nodular hyperplasia of the liver and hepatocellular adenoma (author's transl)]. 61
230375 1979
924
Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. 61
221698 1979
925
Bioassay of 2-nitro-p-phenylenediamine for possible carcinogenicity. 61
12799694 1979
926
[Myeloproliferative disorder and hepatocellular adenoma following androgen treatment of a patient with aplastic anemia (author's transl)]. 61
216824 1978
927
Carcinogenic effect of N-nitrosobis(2-hydroxypropyl)-amine in rabbits. 61
728889 1978
928
[Hepatocellular adenoma of the liver (1 case)]. 61
216148 1978
929
Bioassay of 4,4'-thiodianiline for possible carcinogenicity. 61
12844160 1978
930
Bioassay of tris (2,3-dibromopropyl) phosphate for possible carcinogenicity. 61
12830221 1978
931
The association between oral contraception and hepatocellular adenoma--a preliminary report. 61
203498 1977
932
Letter: Hepatocellular adenoma: relationship to oral contraceptives? 61
181604 1976
933
[Hepatocellular adenoma]. 61
185665 1976
934
[Hepatocellular adenoma]. 61
179176 1976
935
Hepatocellular adenoma and oral contraceptives. 61
1272546 1976
936
Tumours of the liver and biliary system. 61
1086149 1976
937
A benign hepatocellular adenoma treated by extended right lobectomy. 61
208450 1976
938
A benign hepatocellular adenoma treated by extended right lobectomy. 61
1267408 1976
939
[A large hepatocellular adenoma of the liver in an 82-year-old patient (histologic and cytometric findings)]. 61
1221993 1975
940
[Hemoperitoneum due to rupture of hepatocellular adenoma]. 61
4423006 1974
941
Massive hemoperitoneum from rupture of benign hepatocellular adenoma. 61
4346374 1973
942
[Hepatocellular adenoma]. 61
5295605 1966
943
[ON THE CLINICAL ASPECTS AND THERAPY OF HEPATOCELLULAR ADENOMA]. 61
14231030 1964
944
[Multiple hepatocellular adenoma of the liver]. 61
13381362 1956

Variations for Hepatocellular Adenoma

Expression for Hepatocellular Adenoma

Search GEO for disease gene expression data for Hepatocellular Adenoma.

Pathways for Hepatocellular Adenoma